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Title: Understanding Breathing and Swallowing in Chronic Obstructive Pulmonary 
Disease via a Holistic Lens 
 
 
Chronic obstructive pulmonary disease (COPD) impacts physiological and 
psycho-emotional aspects of life. COPD-related secondary sequalae also interact with 
each other, creating the potential for a synergistic downward spiral of quality of life. For 
example, dyspnea, one of the most common symptoms of COPD, not only affects the 
severity of breath and the functioning of the body, but also influences the mind (e.g., 
anxiety, panic, fear). This negative psycho-emotional state can then create a further 
cascading effect on the breath and the body. This is particularly relevant during oral 
intake, an activity that is negatively impacted by the high prevalence of dysphagia 
(swallowing impairments) in individuals with COPD. Given the breadth of the impact of 
COPD on multiple facets of health and well-being, it is therefore pivotal to investigate 
more comprehensive approaches to managing COPD, addressing the mind, body, and 
breath simultaneously. Sudarshan Kriya Yoga (SKY), a breath-based meditation 
program, has previously been shown to yield physiological and psycho-emotional 
benefits for other populations, including healthy individuals, veterans, and those affected 
by trauma, anxiety, and depression. Therefore, using qualitative phenomenology and 




well as its functional relation with dyspnea perceptions and mealtime enjoyment and 
difficulty were investigated among individuals with COPD. A total of nine individuals 
with varying severities of COPD participated. Data collection included: semi-structured, 
in-depth interviews; ratings of perceived dyspnea as related to work of breathing, 
shortness of breath, dyspnea-related distress, dyspnea-related anxiety, and mealtime 
enjoyment and difficulty; and surveys on psycho-emotional status (Hospital Anxiety and 
Depression Scale and Positive and Negative Affect Schedule), COPD impact (COPD 
Assessment Test), and oral intake experience (Eating Assessment Test and Dysphagia 
Handicap Index). Results suggested SKY to be feasible and acceptable for individuals with 
COPD. Additionally, the results demonstrated proof of concept that SKY can help alleviate 
aspects of COPD disease burden related to the mind, body, and breath more broadly as well 
as reduce the cyclical effect of the disease sequalae. This study is the first to demonstrate 
that SKY can be a viable complementary and integrative health approach among 
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Chronic Obstructive Pulmonary Disease (COPD) is a life-threatening lung disease 
that is characterized by chronically obstructed airflow in the lungs. It is the third leading 
cause of death in the United States and is projected to continue as a leading global cause 
of death and disability by 2030 (Heron, 2019; Mathers & Loncar, 2006). Its common 
comorbidities include, but are not limited to, anxiety, depression, increased respiratory 
rate, and difficulty swallowing (dysphagia) (Schneider et al., 2010; Shaker et al., 1992; 
Steidl et al., 2014). These comorbidities often contribute to increased mortality and 
morbidities, including COPD exacerbations, admissions/re-admissions to the hospital, 
economic burden associated with increased healthcare expenses, and reduced quality of 
life (Dalal et al., 2011; Hynninen et al., 2005; Pooler & Beech, 2014; Yohannes et al., 
2010; Yohannes et al., 2016). In 2010, the economic burden attributable to COPD was 
$36 billion, including total national medical costs of $32.1 billion and $3.9 billion 
associated with work absenteeism; this number is only expected to increase (Ford et al., 
2015). 
Similar to COPD, dysphagia is also a physiologically-based condition. Breathing 
and swallowing work in synchrony to protect against material from entering the lower 
airway. When these two mechanisms break down or are discoordinated, individuals can 
experience dehydration, malnutrition, aspiration pneumonia, and even death (Eslick & 
Talley, 2008; Jones et al., 2018; Langmore et al., 2002). Individuals with dysphagia are 
more likely to experience a longer hospital stay, higher hospital bills, and a greater 




related psycho-emotional burden is also heavy. Dysphagia can lead to anxiety, 
depression, social isolation, and decreased quality of life (Ekberg et al., 2002; Nund et al., 
2016; Plowman-Prine et al., 2009). Unfortunately, given the current aging demographics 
worldwide and associated increase in concomitant healthcare consequences, the number 
of individuals with dysphagia is also excepted to continue to rise (Leder et al., 2016).  
Both COPD and dysphagia yield physiological (i.e., breath, body) and psycho-
emotional (i.e., mind) consequences. Unfortunately, these mind-body-breath 
consequences can further negatively influence one another. A mind-body-breath 
connection, most basically, suggests that the actions of the mind, body, and breath are all 
interrelated and interdependent, exhibiting bidirectional relations with one another. For 
example, this multidirectional relationship between physiology (mind/body) and 
psychology (brain) is apparent under stressful conditions. A stressful state of mind can 
lead our nervous system into fight-or-flight mode. The activation of the sympathetic 
nervous system is characterized by a faster respiratory rate, an alteration of breathing 
patterns, and a heightened alert state. This triangular relationship is also apparent in the 
context of COPD. The pulmonary deconditioning that occurs in COPD is accompanied 
by resultant dyspnea (i.e., shortness of breath), swallowing difficulties, and comorbid 
anxiety and depression, with the latter often worsening perceived dyspnea and increasing 
the risk of COPD exacerbations (Bentsen et al., 2014; Dalal et al., 2011; Hynninen et al., 
2005). Similar to COPD, dysphagia is also a physiological-driven condition that 
encompasses the mind-body-breath relationship. For example, when respiratory rate is 
high, the airway is at increased risk for being compromised due to the less-than-ideal 




current research has suggested that dysphagia is independently associated with anxiety 
and depression, a body-mind connection (Eslick & Talley, 2008; Santos et al., 2007). 
Despite the interrelatedness between the physical and psycho-emotional 
symptoms and sequelae, each of these components (e.g., COPD symptoms, 
depression/anxiety, dysphagia) is generally treated in isolation (e.g., medication for 
anxiety/depression, exercises for dysphagia). Yet, as the mind, body, and breath levels 
are interconnected and jointly impacted, it is may be more effective to look beyond 
targeted focal remedies. A comprehensive approach aimed at ameliorating disease 
symptoms, consequences, and their interactions while improving quality of life can better 
serve our patients through more person-centered care. That is, apart from the individual 
and overlapping complexities of COPD and dysphagia, both COPD and dysphagia are 
connected within a mind-body-breath framework. As these medical conditions are more 
than just physiological or psychological alone, a broader perspective is needed in order to 
most effectively address their complexity within condition management. To pivot 
towards person-centered care and to develop a more thorough understanding about the 
gaps in dysphagia care in the presence of COPD, it is key to look at these chronic 
diseases through the mind-body-breath lens (Lin & Shune, 2020). Through such a lens, 
the physiological-, psycho-emotional-, and quality of life-related factors can be accounted 
for simultaneously, better targeting whole-person, rather than disease-focused, care.  
Person-centered care, first and foremost, commences with listening to our 
patients’ experiences (Cheraghi et al., 2017; Constand et al., 2014; Resnick, 2017). This 
communication is essential for improved quality of healthcare delivery and outcomes 




globally, person-centered care establishes improved outcomes, patient satisfaction, and 
self-management (Rathert et al., 2013). The failure to transition from disease-centered 
care to person-centered care has yielded a significant gap in our ability to optimize 
patient care targeted at improved overall quality of life (The American Geriatrics Society 
Expert Panel on Person-Centered Care, 2016). Person-centered care helps shift away 
from physiological (or illness-centered) foci alone and encompasses the social, 
emotional, and psychological implications or consequences of that illness — ultimately 
resulting in a more comprehensive management approach. 
One such person-centered care approach that comprehensively addresses the 
mind, body, and breath is Sudarshan Kriya Yoga (SKY) (Brown & Gerbarg, 2005a, 
2005b). SKY is a breath-based meditation program. Previous research on SKY has 
suggested benefits in both the physiological and psycho-emotional domains, including 
relieving anxiety and depression (mind), improving cardiovascular and pulmonary 
functioning (body), and reducing respiratory rate (breath) across populations (e.g., Kale 
et al., 2016; Seppälä et al., 2014; Sharma et al., 2017). Such a comprehensive approach 
may be equally appropriate to address the complexities of COPD and dysphagia in 
particular. 
This study explored the impacts of SKY on the oral intake experience of 
individuals with COPD. This mixed-methods investigation examined participants’ 
qualitative experiences with SKY (i.e., interviews) as well as preliminarily quantified 
SKY’s impact on self-reported outcomes (i.e., mood, pulmonary burden, oral intake 




feasibility and acceptability of a person-centered mind-body-breath approach for COPD 
and COPD-related dysphagia, which can further direct future management. 
Chapter II reviews the literature on COPD, dysphagia, and COPD-related 
swallowing issues. After reviewing the literature, the chapter presents information on the 
mind-body-breath connection in relation to COPD and swallowing. The latter portion of 
the chapter focuses on interventions currently available for COPD and dysphagia and 
introduces the intervention used for the current study. The chapter closes by presenting 
the research questions, hypotheses, and expected findings. Chapter III presents a 
description of the research methods, procedures, and analyses for the current study. The 
chapter describes the experimental design, participant characteristics, and research 
procedures. It also defines and describes the experimental intervention, the outcome 
measures, and methods of analyses for answering the research questions. Chapter IV 
presents the study results. Chapter V presents a discussion of the results relative to the 







REVIEW OF LITERATURE 
The following literature review consists of several sections. The first presents 
information about COPD and its disease characteristics. The second describes 
swallowing and COPD-related swallowing issues. The third describes the mind-body-
breath connection in relation to swallowing and COPD. The fourth discusses the 
intervention to be used in this dissertation study, Sudarshan Kriya Yoga (SKY). The final 
section provides a statement of the purpose and research questions.  
COPD 
COPD is a life-threatening lung disease that is characterized by chronically 
obstructed airflow in the lungs. The mortality associated with this “common, preventable 
and treatable disease” (p. 1, Global Initiative for Chronic Obstructive Lung Disease; 
GOLD, 2020) nearly doubled from 1970 to 2000 (Diaz-Guzman & Mannino, 2014). 
COPD is projected to be the third-leading cause of death (World Health Organization 
(WHO), 2018) and among the top ten causes of disease burden by 2030 (Mathers & 
Loncar, 2006). COPD is commonly associated with symptoms like breathlessness, 
excessive sputum production, and a chronic cough along with comorbid psycho-
emotional impacts, such as anxiety, depression, and reduced quality of life. Individuals 
exposed to tobacco smoking, indoor and outdoor air pollutants, and occupational 
dusts/chemicals are at risk for developing this lung disease (WHO, 2020). According to 
the National Ambulatory Medical Care Survey 2016 released by the Center for Disease 
Control and Prevention (CDC), the number of annual physician office visits with COPD 




patient demographics, an estimated 58% of patients with COPD are female and 42% 
male, and 84% are White, 11% Black or African American, and 6% other (Asian, Native 
Hawaiian or other Pacific Islander, and American Indian, or Alaska Native persons, and 
persons with more than one race). 
Physiological Characteristics 
As an individual breathes, air enters the lower airway from the nose and/or the 
mouth. The trachea branches into two bronchial tubes and the bronchi branch into 
bronchioles, ending with round air sacs, alveoli. Each air sac is covered with capillaries. 
These mesh of tiny blood vessels is where the exchange of oxygen and carbon dioxide 
takes place. Obstructed airways and air sacs can lead to COPD — hindering airflow in 
and out of the lungs as well as gas exchange in the alveoli (National Heart, Lung, and 
Blood Institute, 2019). In 2018, GOLD released a report entitled “Global Strategy for the 
Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease”, 
which detailed the consensus of COPD experts from around the world. Based on the 
report, a summary of the physiological aspects of COPD is provided here.  
 COPD is characterized by chronic respiratory symptoms and airflow limitation as 
a result of airway abnormalities due to significant exposure to noxious particles or gases. 
A mixture of small airway disease and parenchymal destruction can lead to the chronic 
airflow limitation in COPD. The chronic inflammation is a result of structural changes, 
like the narrowing of the small airways and destruction of the lung parenchyma, and it 
can result in alveolar detachment to the small airways and reduced lung elastic recoil. 




trapping and CO2 retention. Airflow limitation and mucociliary dysfunction are also the 
by-products of a loss of small airways.  
 The diagnosis of COPD is recommended to be considered if the presenting 
symptoms include dyspnea, chronic cough, sputum production, and/or history of 
exposure to risk factors for the disease (e.g., tobacco smoke, smoke from home cooking 
and heating fuels, occupational exposure to dusts, fumes). Spirometry is utilized in the 
clinical diagnostic process. Forced expiratory volume in one second, or FEV1, is the 
volume of air that can be forcibly blown out in the first second after a full inspiration. 
Forced vital capacity (FVC) is the volume of air that can be forcibly blown out after a full 
inspiration. The ratio of these two is used in the diagnosis of obstructive and restrictive 
lung diseases. A post-bronchodilator FEV1/FVC < 0.70 indicates reduced persistent 
airflow. The degree of airflow limitation can entail the severity of COPD: mild with 
FEV1 ≥ 80% predicted; moderate with 50% ≤ FEV1 < 80% predicted; severe with 30% ≤ 
FEV1 < 50% predicted; very severe with FEV1 < 30% predicted. 
 The most commonly seen symptom of COPD is chronic and progressive dyspnea. 
Dyspnea can be described by the patients as increased effort to breathe, chest heaviness, 
air hunger, or gasping. Dyspnea is common in COPD, yet often poorly managed (Swan et 
al., 2019). In general, up to 16% of individuals experience dyspnea and up to 25% of 
accidents and emergency admissions are a product of dyspnea (Chin & Booth, 2016). 
Further, COPD-related dyspnea, and dyspnea in general, is often under-recognized and 
undertreated (Smallwood et al., 2018). Despite being a physiologically-rooted condition, 
this subjective experience of difficulty breathing also manifests in the psycho-emotional 




2018). About one in ten individuals experiencing dyspnea present with anxiety (Chin & 
Booth, 2016). Dyspnea is linked to impeded activities of daily living, unplanned 
emergency room visits, and reduced quality of life (Swan et al., 2019). Further, 
individuals with COPD can distinguish affective dyspnea from the effects of chronic 
respiratory disease (Carrieri-Kohlman et al., 1996). Other symptoms of COPD include: 
chronic cough (the first symptom of COPD) that is either productive or unproductive; 
sputum production, intermittent with periods of remission and flare-up; and wheezing and 
chest tightness, variable between days or within a given day. Patients with more severe 
COPD may also present with fatigue, weight loss, and anorexia. 
COPD exacerbations are characterized by increased airway inflammation during 
bacterial or viral infections, or as caused by environmental factors (e.g., pollutants). The 
increased dyspnea during exacerbations can be accounted for by an increased 
hyperinflation of the lungs and gas trapping due to poor gas exchange with reduced 
expiratory flow. Hypoxemia (i.e., low level of oxygen in the blood) can also be a result of 
reduced ventilation/perfusion ratio (VA/Q) (i.e., the quotient of the air that reaches the 
alveoli and the blood that reaches the alveoli via the capillaries).  
In short, significant chronic lung damage is a physiologic result/cause of COPD 
and can be associated with increased dyspnea, chronic cough, and sputum production. 
COPD exacerbations are another physiologic component of the disease process. 
Psycho-emotional Characteristics of Anxiety/Depression and Other Related Health 
Consequences of COPD 
COPD affects not only physiological well-being, but psycho-emotional as well. 




mental health issues. A review was conducted of 81 studies to investigate the 
psychological characteristics of patients with COPD and the impact of these 
psychological characteristics on survival, disease severity, functional disability, and 
quality of life, as well as rehabilitation and treatment (Hynninen et al., 2005). The results 
revealed a high prevalence of anxiety (10% to 100%) and depression (7% to 79.1%) 
among this population. Further, emotional functioning, personality traits, and 
psychopathology scores predicted survival. Personality traits and psychopathology scores 
even predicted mortality better than the pulmonary function measurements did.   
A strong body of research has supported this relationship between COPD and 
depression and anxiety. One large-scale quantitative study examined individuals over the 
age of 50 participating in the 2004 Health and Retirement Survey (Schane et al., 2008). 
Of the 18,588 individuals included in the study, 1,736 self-reported having COPD. The 
authors investigated potential risk factors for depressive symptoms in COPD and the 
prevalence of COPD-related depressive symptoms as compared to depression in other 
chronic illnesses. Results revealed that respiratory symptoms and difficulty walking 
several blocks were major risk factors for depressive symptoms in individuals with 
COPD. Additionally, individuals with COPD were more likely to exhibit depressive 
symptoms as compared to those with other common chronic illnesses (e.g., coronary 
heart disease, stroke, hypertension, diabetes, arthritis, and cancer). Of interest, a similar 
risk for depressive symptoms was shared by persons with COPD and those with 
congestive heart failure. Another large-scale study, involving 35,772 patients with COPD 
and a matched number of participants without COPD, further supported the finding that 




Additional studies using standardized clinical interviews and questionnaires have also 
explored the relationship between COPD and emotional disturbances, like depression and 
anxiety. Twenty medically stable, adult inpatients with mild-to-moderate COPD and 20 
inpatients with orthopedic complaints (control group) completed standardized clinical 
interviews and questionnaires regarding the presence of mental disturbances and 
perceived physical symptoms (Vögele & von Leupoldt, 2008). Compared to the control 
group, the group with COPD showed higher overall psychological distress, including 
anxiety. A positive correlation between anxiety levels and physical symptoms was 
observed in patients with COPD and anxiety disorder, such that the more anxious an 
individual felt, the more perceived physical symptoms were reported. Additionally, the 
long-term course of depression in patients with COPD and its impact were investigated in 
a three-year longitudinal study involving 1,589 patients (Yohannes et al., 2016). The 
results indicated that about one in four patients with COPD demonstrated persistent 
depressive symptoms over the three years.  
Ultimately, COPD increases the risk for long-term depression. Unfortunately, the 
consequences of long-term depression and anxiety in patients with COPD can be 
substantial: comorbid depression and anxiety is associated with increased functional 
disability, healthcare utilization, and mortality and decreased quality of life in this 
population (Yohannes et al., 2010). This clinical and financial burden of depression and 
anxiety have been profiled for individuals with COPD (Dalal et al., 2011). Three 
thousand seven hundred sixty-one patients with COPD and depression/anxiety were 
compared to the same number of individuals with COPD only. Patients with concomitant 




utilize medical expenses. Increased economic burden in the management of COPD in 
individuals with depression was also significant in one- and two-year follow-ups, 
supporting the importance of effective therapeutic management of psychological status. 
Such psychological distress, particularly long-term depression, can also result in 
increased COPD exacerbations (Yohannes et al., 2016). A systematic review and meta-
analysis supported that comorbid psychological distress in the COPD population yields 
an increased risk of COPD exacerbation and, potentially, mortality (Atlantis et al., 2013). 
Researchers have also further studied whether or not the presence of anxiety and 
depression is related to more frequent exacerbations (≥ 2/year) (Montserrat-Capdevila et 
al., 2017). Five hundred and twelve patients with COPD (ages ≥ 40) were monitored for 2 
years. During the study period, those with anxiety/depression were noted to have a higher 
incidence of frequent exacerbations than those without (73.8% versus 50.5%). The 
authors concluded that anxiety and depression are risk factors for frequent exacerbations.  
The negative influence of psycho-emotional impairment is not limited to COPD 
exacerbation alone. Based on a study of thirty patients with mild-to-moderate COPD, 
researchers found that negative affective states can also amplify the perception of 
dyspnea in individuals with COPD (Von Leupoldt et al., 2010). In other words, not only 
can physiological status (e.g., COPD) influence psychological state (e.g., anxiety and 
depression), the inverse holds true as well (e.g., anxiety/depression leading to increased 
COPD exacerbation and increased perceived dyspnea). Together, these findings support 
the interrelationships between the mind, body, and breath in this population. 
Laurin and colleagues (2012) proposed two mechanisms that explain how anxiety 




describes a series of biological pathways. In this model, the increased risk of 
exacerbations is related to the activation of the hypothalamic-pituitary-adrenal (HPA) 
axis as well as the increased systemic inflammatory responses associated with anxiety 
and depression. In other words, immune function may become compromised from the 
chronic activation of the sympathetic nervous system and the hyperactivity of the HPA 
axis as a result of chronic psychological stress. A compromised immune function could 
then lead to the increased risk of respiratory infections and COPD exacerbations seen in 
this population. The other model illustrates more cognitive and behavioral elements. The 
authors suggest that poor disease-coping and self-care behaviors related to low self-
confidence can be a by-product of anxiety and depression. As a result, patients are less 
engaged in pulmonary rehabilitation, tobacco cessation, physical activities, good eating 
habits, and adherence to medical pharmaceutical regimens. The withdrawal from various 
interventions can increase patients’ risk of COPD exacerbations. Additionally, feelings 
associated with depression (e.g., hopelessness, helplessness, isolation, decreased energy) 
and those associated with anxiety (e.g., fear, worry) might keep patients from seeking 
help and also increase their awareness of their physical symptoms. Ultimately, it is clear 
that the relationship between COPD and anxiety and depression is complex.  
Further complicating the picture, the connections between physiological and 
psycho-emotional impairments in individuals with COPD lead to a variety of additional 
consequences. A related study aimed to examine the link between anxiety and depression 
and COPD readmission risk over time (Iyer et al., 2015). Medical records of four hundred 
and twenty-two individuals with a primary diagnosis of acute exacerbation of COPD 




exacerbation of COPD and related to both short-term (30-day and 90-day) and up to one-
year readmissions. An additional systematic review also supported a significant 
relationship between anxiety, depression, and acute COPD exacerbations with resultant 
hospital admissions/readmissions (Pooler & Beech, 2014). The relationship between 
negative affect and physiological impairments appears to have a cascading impact on 
disease outcomes. As suggested earlier, COPD has also been linked to a number of health 
consequences known to increase mortality and economic burden and decrease quality of 
life, such as aspiration pneumonia, more frequent hospital (re)admissions, and increased 
length of hospital stays (Pooler & Beech, 2014).   
Apart from, or perhaps related to, the increased exacerbations and swallowing-
related issues, COPD-related anxiety and depression can also have a negative influence 
on quality of life. A study of 100 patients with COPD was conducted to understand the 
relationship among anxiety, depression, and disease-specific quality of life as well as 
generic quality of life (Bentsen et al., 2014). Results indicated that COPD-associated 
anxiety and depression can negatively impact quality of life. Specifically, age and level 
of anxiety were related to disease-specific quality of life. That is, worse disease-specific 
quality of life was reported by younger individuals with COPD and persons with higher 
levels of anxiety. Further, worse generic quality of life was evident in patients with 
higher depression scores. Negative affect plays a seemingly key role in individual well-
being. Relatedly, a two-year longitudinal study that involved 336 patients was carried out 
to examine COPD exacerbations and their associated impact on quality of life 
(Miravitlles, 2004). Over the course of the longitudinal study, a total of 1,050 cases of 




average). About 31% of the patients were hospitalized for exacerbations. The authors 
reported that the health-related quality of life of individuals with moderate COPD was 
adversely affected by frequent exacerbations. A review of 81 studies investigated the link 
between psychological characteristics and various aspects of life (e.g., illness, heath, 
quality of life) (Hynninen et al., 2005). The study revealed that psychological disorders 
are prevalent in individuals with COPD, which can impact their daily functioning and 
lead to resultant functional disability. The psychological characteristics were also 
associated with reduced quality of life and were a predictor of rehabilitation outcomes 
and survival. Together, these findings support that COPD is a cause of morbidity and 
disability. Psychological well-being can ultimately be linked to a variety of 
consequences.    
Finally, researchers have looked at the relationship between COPD and brain 
structure, with notable findings related to the physiological and psycho-emotional links 
described above. Of interest, COPD has been reported to be associated with structural 
brain changes (Esser et al., 2016). Thirty stable individuals with moderate-to-severe 
COPD were compared to a control group (age, sex, and BMI-matched participants 
without a history of respiratory disease) to illustrate the structural changes of the brain in 
relation to COPD, disease duration, and disease-specific fears. The authors reported a 
reduction in gray matter in the posterior cingulate cortex, anterior and midcingular cortex, 
hippocampus, and amygdala in the COPD group — areas in the brain that are related to 
processing dyspnea, fear/anxiety, and fear-avoidance behavior. Additionally, the 
decreased gray matter in the anterior cingulate cortex was correlated with longer disease 




of dyspnea and physical activity, these changes in the brain structure can further impact 
the course of the disease negatively (e.g., exercise, rehabilitation).  
In summary, COPD and its consequences are not only exhibited physiologically 
within the body and the breath (e.g., shortness of breath, increased effort to breath, 
wheezing, aspiration pneumonia), but also psycho-emotionally (e.g., anxiety, depression). 
COPD-associated anxiety and depression can be further linked to increased 
exacerbations, hospitalizations, length of hospital stays, and economic burden, decreased 
quality of life, and even changes in brain structures related to fear of dyspnea and 
physical activity. Given the broad spectrum of consequences and multi-system 
manifestations of COPD, a more comprehensive management approach that encompasses 
a mind-body-breath framework may be more effective at improving patient outcomes and 
may better promote a more person-centered care model. 
Dysphagia in COPD 
Dysphagia, operationally defined as swallowing difficulties, can also be a 
comorbidity of COPD. It can result in aspiration, pulmonary-related complications, 
dehydration, and malnutrition (Cichero et al., 2013; Marik & Kaplan, 2003). Like COPD, 
dysphagia also affects both the physiological and psycho-emotional domains.  
Anatomically, the upper airway is a shared space involved in the coordination 
between breathing and swallowing to meet nutritional, hydrational, and necessary 
medical needs. Synchronization between the breathing and swallowing mechanisms 
prevents material from entering the lower airway (i.e., aspiration), especially during oral 
intake. One component of such coordination is a short protective cessation of respiration 




mechanisms, a characteristic of dysphagia, is not uncommon among individuals with 
COPD. Despite frequent reports that it is common, the exact prevalence of dysphagia 
among individuals with COPD across the general population is unknown (O’Kane & 
Groher, 2009). Yet, COPD has been reported to be the second strongest predictor for 
dysphagia-related aspiration pneumonia among nursing home residents (Langmore et al., 
2002; Santo et al., 2021).  
Perhaps partially underlying the increased risk for pulmonary issues such as 
aspiration pneumonia, COPD contributes to impairments in the swallowing process. For 
example, a literature review of 19 studies revealed a relationship between dysphagia and 
COPD exacerbations in patients with impaired respiratory-swallow patterns (Steidl et al., 
2014). A retrospective investigation on the prevalence and nature of dysphagia among 
outpatients with COPD with suspected dysphagia who were referred for an instrumental 
fluoroscopic swallow study (modified barium swallow; MBS) revealed that 84.6% did 
indeed present with dysphagia upon evaluation (Good-Fratturelli et al., 2000). Another 
study examined the prevalence of dysphagia-related symptoms in individuals with 
COPD, with a particular focus on gastroesophageal reflux (GER) symptoms (Mokhlesi et 
al., 2001). The results suggested that individuals with mild-to-severe COPD had an 
increased prevalence of subjective swallowing complaints and GER symptoms (17%) 
when compared to those in the control group without COPD (3%). Further, with the aim 
of understanding swallowing function in patients with mild COPD, two dysphagia tests 
(Two-step Swallowing Provocation Test; Repetitive Saliva Swallowing Test) were used 
to examine dysphagia prevalence (Ohta et al., 2009). There was evidence of dysphagia 




of abnormal to normal swallows than the control group (6 vs. 0). Given the results 
suggestive of the presence of dysphagia in mild COPD, the authors suggested that 
continued monitoring of COPD patients’ swallowing function is warranted. More 
recently, Garand et al. (2018) reported that underweight individuals with advanced but 
stable COPD exhibit dysphagia that may not be self-recognized. Further, quantitative 
analyses of swallowing function have suggested that individuals with stable COPD 
present with both swallowing safety and swallowing efficiency impairments (Mancopes 
et al., 2020). These impairments were characterized by impaired mechanism, timing, and 
duration of the laryngeal vestibule closure as well as increased pharyngeal residue due to 
poor pharyngeal constriction.  
Dysphagia substantially impacts mortality, quality of life, and economic burden. 
A sample of U.S. hospital discharge data from 2009 – 2013 reported that that individuals 
with dysphagia (ages 45 – 90) have longer hospital stays, higher hospital bills, a greater 
likelihood of needing a post-discharge medical placement, and lower inpatient survival 
rates as compared to individuals without dysphagia (Patel et al., 2018). Individuals with 
dysphagia also frequently experience anxiety, social isolation, and decreased quality of 
life (Allen et al., 2019; Marik, 2001; Shune et al., 2012). Therefore, although dysphagia 
is a physiological condition in nature, it influences life multidimensionally, similar to 
COPD more broadly.  
The following sections will review COPD-related respiratory-swallow patterns 







Respiration patterns play a key role in swallowing in order to protect against food 
and liquids entering the lower airway. Yet, the timely and efficient coordination of the 
breathing and swallowing mechanisms is often impaired among persons with COPD. To 
provide a foundation for understanding dysfunction, this section first discusses the typical 
respiratory-swallow pattern observed in most healthy adults. The complex coupling of the 
respiratory and the swallowing mechanisms and how they work together in the presence 
of COPD will then be reviewed. 
 Multiple studies have examined the typical synchronization between breathing 
and swallowing coupling during oral intake. A larger-scale systematic investigation into 
respiratory swallowing patterns in healthy individuals revealed a number of distinct 
profiles (Martin-Harris et al., 2005). MBS studies were conducted in 82 healthy adults. 
During the studies, the participants self-administered 5 mL liquid barium sulfate contrast 
solution twice. Data on the respiratory phase and swallow apnea were recorded via the 
Swallow Signals Lab. The results suggested that there are four potential respiratory-
swallow patterns: 1) expiratory-swallow-expiratory, 2) expiratory-swallow-inspiratory, 3) 
inspiratory-swallow-expiratory, and 4) inspiratory-swallow-inspiratory. That is, the 
action of swallowing can be either immediately preceded or followed by inhalation or 
exhalation. This study concluded that the first pattern, where the swallow is sandwiched 
in between expiratory flows, is the most common pattern observed in healthy individuals. 
The larynx is positioned in a paramedian position during expiratory phase. This adducted 
arytenoid/vocal fold positioning of the true focal folds before or after the swallowing is 




during inhalation. Additional advantages of having expiration before and after swallow 
include: (a) during expiration, the diaphragm is relaxed with the larynx elevated (vs. 
during inspiration, the diaphragm contracts with the larynx lowered), which allows for a 
more optimal position for airway protection for the epiglottis to fully invert and cover the 
larynx (Martin-Harris et al., 2015); and (b) swallowing followed by expiration can help 
expel penetrated material out of the airway (Martin et al., 1994). Additional normative 
data on the respiratory-swallow pattern has also been previously reported based on data 
from 21 healthy adults (Martin-Harris et al., 2003). The most predominant phase 
coupling pattern was again expiratory-swallow-expiratory (79% to 82% of the trials), 
followed by inspiratory-swallow-expiratory (18% to 21% of the trials). 
The coordination between breathing and swallowing has also been investigated 
specifically in the COPD population. Gross et al. (2009) aimed to examine the 
respiratory-swallow patterns in patients with moderate-to-severe COPD. The patterns 
were compared between 25 participants with stable COPD and 25 participants in a 
healthy control group. The authors concluded that the coupling of the breathing and 
swallowing cycle is disrupted in the presence of COPD, even when the disease is stable. 
The individuals with COPD exhibited inspiratory-swallow-inspiratory patterns 
significantly more often than the healthy control participants. Additionally, in a study of 
16 patients with moderate COPD and 15 healthy age- and gender-matched individuals, 
the authors reported that the inspiratory-swallow-expiratory pattern was found to be more 
common in individuals with COPD, while expiration-swallow-expiration coupling was 
more frequently observed in healthy controls (Cvejic et al., 2011). Further, individuals 




often during exacerbated states as compared to their basal state (Shaker et al., 1992). 
Both stable and exacerbated COPD states have, in fact, been found to yield significantly 
different respiratory-swallow patterns when individuals with COPD are compared to age-
matched elderly participants. Such disruption in coordination, namely inhaling before and 
after swallows, is likely to contribute to episodic suboptimal airway protection during 
swallowing and is concerning for pulmonary compromises, such as aspiration, aspiration 
pneumonia, as well as subsequent COPD exacerbations. Beyond the physiological effect 
on the respiratory system itself that could contribute to exacerbation, the anxiety that can 
be related to aspiration can further magnify the negative consequences and result in 
future exacerbation events. 
Swallowing dysfunction in COPD, including respiratory-swallow discoordination 
and subsequent aspiration (i.e., material enters the lower airway below the larynx) and 
penetration (i.e., material remains above the larynx in the laryngeal vestibule), may also 
be related to alterations in respiratory rate. To better understand the impact of respiratory 
rate on swallow function, Shaker and colleagues (1992) compared 10 healthy younger 
adults (ages 18 – 34), 11 healthy older adults (ages 63 – 83), and 22 individuals with 
COPD (ages 46 – 77). Swallowing and respiration were recorded for all three groups at 
rest. In addition, the young healthy individuals were exerted via a stationary exercise 
bicycle to increase their respiratory rate to 20-24, 25-29, and 30-34 breaths per minute. 
Then their swallowing and respiration cycle data were collected again. For individuals 
with COPD, data was also collected at two points of time: during an exacerbated state in 
the emergency room and during a basal state (once the exacerbation subsided). When the 




changes in the respiratory-swallow pattern were observed in dry swallows. When the 
respiratory rate was 30-34 breaths per minute, changes in respiratory-swallow pattern 
were noted with water swallows. Participants with COPD, in both stable and exacerbated 
states, also presented with a higher respiratory rate than the healthy controls (both the 
young and elderly). Increased respiratory rate and exacerbations appear to result in the 
alteration of the airway protection mechanism, modifying the intimate relationship 
between respiration and swallowing and reducing swallowing safety. Furthering Shaker’s 
findings (1992), increased respiratory rate has also been associated with compromised 
airway protection (i.e., penetration or aspiration) in individuals with COPD (Cvejic et al., 
2011). Sixteen patients with moderate COPD and fifteen healthy age- and gender-
matched individuals participated in the study. Half of the individuals with COPD 
exhibited increased respiratory rate at rest (>25 breaths per minute) with resultant 
penetration/aspiration. Increased baseline respiratory rate and lower baseline oxygen 
saturation were also associated with the presence of penetration/aspiration. Namely, a 
compromised pulmonary status at baseline may be predictive of airway invasion. 
In conclusion, for individuals with COPD, uncoordinated respiratory-swallow 
patterns contribute to airway invasion. The suboptimal respiratory-swallowing coupling 
puts this population at increased risk for aspiration and penetration. Notably, too, when 
respiratory rate is high, even in the healthy population, airway protection can be 
compromised. Finally, while the discoordinated respiratory-swallow patterns are risk 
factors for aspiration and penetration, the psycho-emotional status may also be negatively 
impacted (e.g., increased fear or anxiety related to aspiration), which may, by extension, 




COPD-Related Dysphagia Characteristics 
Multiple studies have characterized the oropharyngeal swallowing physiology of 
individuals with COPD. Characteristics of dysphagia are noted across the oral, 
pharyngeal, and the esophageal phases of the swallowing process, including decreased 
laryngeal elevation during swallowing and longer laryngeal closure times relative to the 
cricopharyngeal opening (Mokhlesi et al., 2002). These impairments pose a particular 
risk for safely consuming oral intake. 
For many individuals with COPD, the swallow physiology is impacted across the 
length of the swallow sequence and a wide range of dysphagia features, particularly in 
the oral and pharyngeal stages of swallowing, have been reported. One study 
characterized the oropharyngeal swallow in patients with stable COPD using MBS 
(Mokhlesi et al., 2002). Participants included 20 patients with stable COPD and 20 age- 
and sex-matched controls with no history of any disorder that could lead to 
oropharyngeal dysphagia. Four individuals with COPD reported subjective complaints of 
mild and intermittent dysphagia (20%). None of these four had previously complained of 
these symptoms prior to study participation. MBS results revealed varying disordered 
swallowing characteristics in different stages of swallowing. They included: reduced 
tongue control, reduced anterior-posterior tongue movement, reduced lingual 
stabilization, reduced tongue strength, delayed pharyngeal swallow, reduced tongue base 
retraction, slowed/delayed vestibule closure, reduced laryngeal elevation, and visible 
cricopharyngeal bar. Based on these results, COPD is associated with abnormal 
swallowing physiology. In another study, 14 individuals with COPD referred for 




clinical swallowing and MBS exams (Coelho, 1987). The participants’ dysphagia was 
characterized by consistent aspiration (3/14; 21%) and dysfunctions in bolus control 
(6/14; 43%), lingual peristalsis (10/14; 71%), swallow reflex initiation (5/14; 36%), 
pharyngeal peristalsis (10/14; 43%), and cricopharyngeal opening (1/14; 7%). Of note, 
some of the participants in this study had structural or mechanical alterations of the 
oropharynx, related to, for example, the presence of a tracheostomy tube or being 
ventilator-dependent. Similarly, an abnormal swallowing reflex has been found to be 
significantly more prevalent in individuals with COPD as compared to age-matched 
controls (22/67 vs. 1/19) (Terada et al., 2010). Other studies have found similar results, 
with individuals with COPD demonstrating delayed pharyngeal swallow response, 
laryngeal penetration, silent aspiration, and oral, vallecular, and pyriform sinus stasis 
(Good-Fratturelli et al., 2000). The specific association between cricopharyngeal (CP) 
function in COPD was studied in individuals with moderate-to-severe COPD (Stein et al., 
1990). Twenty-five participants completed either cineradiography or videofluoroscopic 
gastrointestinal exams. The findings revealed a significant relationship between CP 
dysfunction and frequent exacerbations and that there was a high prevalence of CP 
dysfunction among the individuals with COPD (84%; 21/25). Eight of ten of the 
participants with severe CP dysfunction underwent cricopharyngeal myotomies with 
reported improved swallowing and relieved symptoms acute exacerbation of respiratory 
distress. Ultimately, COPD can negatively impact all of the stages of swallowing 
physiology, including the oral, pharyngeal, and esophageal stages, negatively impacting 
both swallowing efficiency and safety (Mancopes et al., 2020). When these 




coordination dysfunction, the consequences can be particularly severe, increasing the risk 
for pulmonary complications like aspiration pneumonia.    
 Finally, and relatedly, individuals with COPD experiencing an acute exacerbation 
are more likely to demonstrate an impaired swallow reflex as compared to patients with 
stable COPD (Kobayashi et al., 2007). Further, individuals with COPD who demonstrate 
an abnormal swallowing reflex present with a significantly higher occurrence of 
exacerbations (Terada et al., 2010). Therefore, dysphagia can serve as a risk factor for 
COPD exacerbation, and vice versa.  
Dysphagia-Related Psycho-Emotional Characteristics and Quality of Life  
Physiological consequences aside, dysphagia also results in many psycho-
emotional consequences across populations. Although not extensively studied among 
individuals with COPD, dysphagia, in general, is a known risk factor for anxiety and 
depression. Additional areas that are impacted include quality of life, social engagement, 
personal identity, and the burden placed on the caregivers of individuals with dysphagia. 
In the development of SWAL-QOL, a swallowing quality of life outcomes tool, 
McHorney et al. (2002) reported that “33% of these dysphagic patients would screen 
positive for major depression” (p. 105). This result has been supported and expanded on 
by many subsequent studies. Two hundred and forty-five nursing home residents, ages 65 
or above, participated in a study examining their mental well-being (Chow et al., 2004). 
All participants had normal or mildly impaired cognition. The results revealed that 
swallowing difficulties was one of eleven significant risk factors for depressive 
symptoms. Another study aimed to understand the root of the depressive symptoms 




et al., 2004). Interestingly, the depressive symptoms were related to the swallowing 
problem items on the ALS Functional Rating Scale, but not to the total ratings. Further 
illustrating the impact of dysphagia on psycho-emotional wellness, in another study, 
1,000 randomly sampled adult individuals completed a validated self-report questionnaire 
to assess the potential presence of dysphagia (Eslick & Talley, 2008). Of those who 
reported the presence of dysphagia (vs. absence), the prevalence of clinical depression 
was 7% vs. 5%; anxiety 20% vs. 14%; and neuroticism 18% vs. 13%. Relatedly, 36 
patients with idiopathic Parkinson’s Disease completed self-report assessments, 
regardless of their swallowing status/function (Plowman-Prine et al., 2009). Results 
revealed that dysphagia is indicative of reduced quality of life and that reduced swallow-
related quality of life is suggestive of depression. Finally, in a retrospective study of 73 
patients with complaints of dysphagia post head-and-neck cancer-related surgical and 
non-surgical managements, the severity of dysphagia was found to be associated with 
anxiety, depression, and decreased quality of life (Nguyen et al., 2005).  
Dysphagia can certainly also impact quality of life in individuals with chronic 
disease, and reduced quality of life further predicts survival. In a systematic review of 35 
studies (Jones et al., 2018), the authors concluded that oropharyngeal dysphagia can 
decrease health-related quality of life. Further, among 495 participants with head-and-
neck cancer, pain, eating, and speech domains of quality of life were associated with 
survival, after controlling for age, time since diagnosis, marital status, education, tumor 
site and stage, comorbidities, and smoking status (Karvonen-Gutierrez et al., 2008). The 




Eating is a social process, with food being intricately tied to culture; 
unfortunately, changes in these related practices can alter an individual’s perceived 
identity and decrease their social participation. When the mealtime is interrupted by 
dysphagia, a host of psycho-emotional consequences (e.g., unenjoyable mealtime, anxiety 
or panic during mealtime), loss of self-esteem, social isolation, and consequent reduced 
quality of life can arise (Ekberg et al., 2002; Hambraeus et al., 1986). Further, the quality 
of social relationships and self-identity can be affected by eating-related activities, and 
the impact of eating-related difficulties in a chronic disease can be magnified by further 
isolating an individual from their social networks (Klinke et al., 2013; Mintz & Du Bois, 
2002; Perry & McLaren, 2003; Plastow et al., 2015). Clearly a variety of psycho-
emotional and social consequences of dysphagia coexist with the physiological burden of 
the dysphagia itself. Given the frequent presence of dysphagia among individuals with 
COPD (O’Kane & Groher, 2009), it is likely that dysphagia then contributes to the 
psycho-emotional impacts of COPD on these individuals.  
Moreover, dysphagia can even impact caregivers’ quality of life, from their food 
experience to their social lives (Nund et al., 2016). The effects of dysphagia on the 
caregiver can include the disruption of caregivers’ daily lives, the need for caregivers to 
make adjustments in order to meet the needs of their partners with dysphagia, a mismatch 
between the reality of the dysphagia and caregivers’ expectations, and questionable 
experiences with services — all adding onto the burden of a caregiver. In a systematic 
review on the burden of caregivers of community-dwelling older adults with dysphagia, 
the presence of dysphagia and having worsening feeding-related behaviors was found to 




2018). The use of a feeding tube was also linked to feelings of heavy burden. Thus, 
unfortunately, the cascading effect of dysphagia extends beyond the individual to the 
family level.    
 In summary, anxiety, depression, social isolation, decreased quality of life, and 
caregiver burden can all result from dysphagia. Ultimately, the consequences of 
dysphagia are not limited to the physiological realms, as both mental well-being and 
quality of life can be adversely affected by the presence of swallow dysfunction. 
Mind-Body-Breath Feedback Loop 
As illustrated thus far, both COPD and dysphagia are physiological-based 
conditions; however, the consequences extend beyond the body level, reaching the mind 
and the breath domains. The subsequent psycho-emotional sequalae can create a domino 
effect on the disease, worsening the already impaired physiological status, which may 
further cyclically impact the psycho-emotional domain (Lin & Shune, 2020). This 
feedforward and feedback loop can be framed within in a mind-body-breath framework, 
emphasizing the interrelatedness of the physiological and psycho-emotional aspects of 
the diseases. 
The mind, body, and breath are more than just separate entities, but rather have an 
intimate relationship with one another (Philippot et al., 2002). The mind-body-breath 
connection, most basically, suggests that the actions of the mind, body, and breath are all 
interrelated and interdependent (see Figure 1). For example, this multidirectional 
relationship between physiology (mind/body) and psychology (brain) is apparent under 
stressful conditions. A stressful state of mind can lead our nervous system into fight-or-




faster respiratory rate, an alteration of breathing patterns, and a heightened alert state. The 
triangular relationship may be particularly true for individuals with COPD and dysphagia 
given the physiologic nature of their impairments in combination with the psychological 
consequences of each disease. 
 
Figure 1. Mind-body-breath connection  
 
While dysphagia is typically considered a more physiologically-focused disorder, 
it also presents with a comprehensive mind-body-breath connection. For example, 
dysphagia has a strong physiologic base, exhibiting itself in the oral, pharyngeal, and/or 
esophageal stage of the swallow as a result of structural, mechanical, and/or neurological 
impairments. These are the common foci of treatment (McHorney et al., 2000). Yet, 
dysphagia can also be accompanied by anxiety and depression resulting from the 
swallowing impairments (bodymind) (Eslick & Talley, 2008; Hillemacher et al., 2004; 
Lun Chow et al., 2004; Plowman-Prine et al., 2009). When individuals are experiencing 
negative emotions, such as depression, they often do not have the same interest in food 
intake (mindbody) (Santos et al., 2007). Further, breath is a vital source of energy for 
keeping the body alive and the cessation of breath (i.e., a short period of apnea) also 




the lower airway (breathbody). However, for a patient who is air hungry, or is 
experiencing the sensation of not enough oxygen, particularly when given a compromised 
pulmonary status (e.g., an individual with COPD), the body will open the airway to 
breathe for survival reasons despite the need to close the airway during swallowing 
(bodybreath). In this situation, two opposing systems (i.e., open vs. closed airway) 
often lead to airway protection issues and consequent aspiration. As a result, aspiration 
pneumonia may develop and the patient’s respiratory load becomes even heavier. More 
subtly at the mind-breath level, there exists a bidirectional relationship between 
respiration and emotion. Respiration can influence emotion, and vice versa (Arch & 
Craske, 2006; Boiten et al., 1994; Kaushik et al., 2006) In the case of COPD, 
compromised pulmonary status (breath) is often associated with anxiety (mind), which 
exacerbates the respiratory system (breath) and results in further increased anxiety (mind) 
(Dudley et al., 1980). 
As particularly relevant to individuals with COPD and swallow dysfunction, the 
intimate interrelationship between the mind and breath among individuals with COPD 
has also been researched. Fundamentally, dyspnea, according to the American Thoracic 
Society (1999) is:  
The subjective experience of breathing discomfort that consists of qualitatively 
distinct sensations that vary in intensity. The experience derives from interactions 
among multiple physiological, psychological, social and environmental factors, 
and may induce secondary physiological and behavioral responses. (p. 322)  
 
Dyspnea is closely related to both COPD and swallowing: this common symptom among 
individuals with COPD (Carrieri-Kohlman et al., 2001) is a key contributor to functional 
performance difficulties (Leidy, 1995), and it can lead to increased respiratory rate, 




Dyspnea, like pain, is a sensory experience that is perceived, interpreted and rated by the 
experiencer (Carrieri et al., 1984). Individuals with COPD are able to rate the sensation 
of breathing effort and discomfort, which suggests that there are both physiological and 
psycho-emotional aspects of dyspnea: the sensory (i.e., intensity of sensation) and the 
affective dimensions (i.e., unpleasantness or distress) (Steele & Shaver, 1992). 
Interestingly, the well-known viscous cycle of anxiety-dyspnea-anxiety (Dudley et al., 
1980) can be mediated through exercise training (i.e., exercising on treadmill at 
increasing levels of speed and grade with coaching), where dyspnea-related anxiety can 
decrease even in the absence of an improvement in shortness of breath (Carrieri-Kohlman 
et al., 2001). Namely, the anxiety related to dyspnea, like other fearful stimuli (e.g., pain), 
can decrease with concomitant coaching about coping strategies and repeated exposure 
(Carrieri-Kohlman et al., 1993). This indicates that the affective-related dyspnea (vs. 
sensory-related dyspnea) can be managed and the viscous cycle can be disrupted when 
considering the disease more broadly. Given the close connection between the mind, 
body, and breath, particularly in chronic illness, there is a clear need to look beyond 
physiological impairment or psycho-emotional deficit in isolation and to target 
interventions at the individual as a whole. Therefore, COPD-related dysphagia may be 
better understood through a more comprehensive lens that incorporates a mind-body-
breath model.  
In our previous synergistic review of COPD and dysphagia, we integrated the 
mind-body-breath model into a framework for understanding COPD, dysphagia and their 
related sequalae (Lin & Shune, 2020). We concluded that the comorbid anxiety and 




and secondary disease sequalae (e.g., social isolation, economic burden, decreased 
quality of life). The secondary sequalae then, in turn, further impact the psycho-
emotional domains, worsening anxiety and depression. See Figure 2 for a graphical 
representation of this process. It is clear that affective states (e.g., anxiety, depression) 
both manifest from and create respiratory burden and physiological consequences (e.g., 
exacerbation) and also yield multifaceted psycho-emotional loads (e.g., social isolation, 
economic burden, quality of life).  
 
Figure 2. Mind-body-breath connection in relation to COPD and dysphagia — 
reproduced under the creative common license (Lin & Shune, 2020). 
 
Taken together, given the complexity of the feedback and feedforward loops 
involved in COPD and dysphagia and the involvement of aspects of the mind, body, and 
breath, focusing on one component in isolation might not yield the systemic 
improvements desired across the whole person. Instead, focusing on more holistic 













physiology of COPD-related dysphagia and the anxiety/depression may, by extension, 
better eliminate the further cascading consequences of the disease (Figure 2). A 
comprehensive person-centered care that takes the mind-body-breath relationship into 
consideration, therefore, may better address the synergistic connection of the different 
systems. 
Treatment Options in COPD and Dysphagia 
Traditional Treatments 
COPD and dysphagia treatments have largely centered around addressing 
physiological impairment or a single psycho-emotional consequence at a time. For 
example, dysphagia diet modifications and rehabilitative or compensatory strategies to 
target swallow dysfunction are common (Garcia & Chambers, 2010; McHorney et al., 
2000). While these management approaches (e.g., oropharyngeal dysphagia 
interventions) do offer support in decreasing symptom severity and improving health-
related quality of life (Jones et al., 2018), the psycho-emotional consequences can play a 
bigger role in life as the affective burden can increase somatic complaints (Verdonschot 
et al., 2013, 2017). In fact, the perception of improved quality of life may be limited 
despite improved swallowing function (Patterson et al., 2014). Relatedly, the actual 
impairment level may not be truthfully reflected in the patient-perceived handicap. That 
is, even with a minimal degree of improvements in the impairment, patients do not 
always see the improvements mirrored in the perceived handicap (Ward et al., 2002). 





Similarly, in COPD, the psycho-emotional consequences can create a snowball 
effect, like increased exacerbation, economic burden, and hospital re-admissions. Yet, 
many treatments commonly used to treat the depression/anxiety and/or the COPD, such 
as antidepressant drug therapy, pulmonary rehabilitation, cognitive behavioral therapy, 
education, and self-management, have shown a paucity of evidence for treatment 
outcomes for improving the comorbid anxiety and depression (Yohannes et al., 2010) and 
have inconclusive long-term benefits (Yohannes et al., 2017). Not only has the efficacy 
of psychopharmacological treatment in COPD shown to be limited, patients are often 
reluctant to take additional medication (Farver-Vestergaard et al., 2018). The delivery of 
pulmonary rehabilitation has also been questioned in a narrative review (Ambrosino & 
Fracchia, 2019). The authors suggested that issues like the high number of patients 
accessing health facilities, high costs of programs, and acceptability can all pose an issue 
for patients when participating in pulmonary rehabilitation. Fear of dyspnea and exercise 
can also be related to rehabilitation program adherence (Harrison et al., 2015). 
Unfortunately, the well-documented presence of disease-related anxiety and depression 
often impede the progress of disease management. Anxiety and depression have been 
reported as significant predictors of poor adherence to COPD interventions, including 
pulmonary rehabilitation (Yohannes et al., 2010).  
Given the cascading negative effects anxiety and depression have on swallowing 
and pulmonary somatic complaints, quality of life, and other socio-economic burden, 
there is a need to target negative affect in management approaches. First, more research 
and resources in the management of anxiety and depression in individuals with COPD 




body-breath lens may more comprehensively target person-centered care; yet this is 
unknown. The utilization of a comprehensive lens, incorporating the physiological and 
the psycho-emotional aspects of life, can likely yield a more holistic outcome. That is, by 
managing anxiety and depression (the mind) in concert with the breath (as illustrated in 
Figure 2), we may be able to prevent further exacerbations and other secondary sequalae 
from taking place.  
Complementary and Integrative Health Interventions 
A growing body of literature has supported meditation-based interventions to 
alleviate anxiety and depression and to improve physiological and psychological well-
being (Singleton et al., 2014; Wielgosz et al., 2019). While complementary and 
integrative health interventions have not been explored as a treatment approach for 
individuals with dysphagia, these complementary and alternative health interventions 
have been previously researched among individuals with COPD in terms of managing the 
disease, although the research remains limited and results mixed. For example, one study 
examined the use of meditation-focused mind-body classes on individuals with stable 
COPD in the community (Chan & Lehto, 2016). The authors employed concentration and 
insight meditation skills as well as mind-body exercises over eight weekly one-hour 
meetings. The participants showed significant improvement in physical and emotional 
symptoms, including improved overall breathing, less severe dyspnea exacerbations, 
improved mood, less reactivity, less anxiety related to the COPD, and better acceptance 
of their COPD. The efficacy of combined mindfulness-based stress reduction (MBSR; 
eight weeks) and relaxation response training (two weeks) was investigated in a 




showed no improvement in dyspnea, health-related quality of life, 6-minute-walk test 
distance, exacerbation rates, stress, or mindfulness. The authors also reported low 
retention, which may have impacted the findings. Further, a pilot study investigated the 
feasibility and efficacy of a 12-week yoga program (yoga postures and timed breathing) 
and its impact on dyspnea intensity and dyspnea-related distress (Donesky-Cuenco et al., 
2009). They found that yoga training was safe and feasible for individuals with COPD. 
There was a greater reduction in distress caused by dyspnea than dyspnea intensity after a 
6-minute walk test, indicating that dyspnea-related distress can be managed through 
yoga. This program also improved the 6-minute walk distance and self-reported 
functional performance. Some positive changes in muscle strength and health-related 
quality of life were also reported. The review of complementary and integrative health 
interventions thus far indicates that some programs help improve physiology and psycho-
emotional aspects among individuals with COPD while others do not. However, the 
previous literature all employed differing breathwork or meditation techniques, or a 
combination of both. Unfortunately, there is a lack of standardized interventions used in 
the previous literature. That is, the design of the interventions were a fusion of different 
components or multiple approaches. Additionally, these programs required multiple 
weeks of time commitment. Given the fact that individuals with COPD have been 
reported to have questionable adherence to treatment (Janssens et al., 2019), a shorter 
program with less time involvement may be more effective in this population. 
Breathing-related rehabilitation (e.g., re-training the respiratory coordination 
pattern) has also been investigated among individuals with dysphagia and individuals 




has been investigated in the head-and-neck cancer population (Martin-Harris et al., 2015). 
Thirty participants with dysphagia re-learned the typical coordination patterns given 
visual feedback of respiratory phase and lung volume for swallow initiation to help them 
learn a more optimal timing to elicit a safe swallow. Such retraining has also been 
completed among individuals with anoxic brain injury. Using single-case methodology, 
clinical improvements in the coordination of respiratory-swallow coordination were also 
reported for the participant following the intervention (Curtis et al., 2020). These results 
demonstrate that improvements in respiratory-swallow coordination can be obtained, 
thereby improving swallow safety.  
Similarly, breathing exercises have been studied in the COPD population to 
investigate their effects on dyspnea and quality of life (Ubolnuar et al., 2019). A 
systematic review and meta-analysis of 19 studies showed that pursed-lip breathing, 
ventilatory feedback plus exercise, diaphragmatic breathing exercise, combined breathing 
exercises, and singing can improve ventilation and quality of life. However, given low-
to-moderate quality of evidence, a strong conclusion was not able to be drawn. Another 
systematic review evaluated controlled breathing exercises (i.e., diaphragmatic breathing, 
pursed-lip breathing, yoga breathing) and respiratory muscle training (i.e., strengthening 
the respiratory muscles) — both often used to improve dyspnea (Borge et al., 2014). It 
was concluded that pursed-lip breathing can improve breathlessness, and respiratory 
muscle training can play a role in improving breathlessness, fatigue, and disease-specific 
quality of life. A single study within this systematic review showed that yoga breathing 
can improve lung capacity after two months of training for individuals with mild and 




rehabilitation suggests that breathing can be trained and/or re-learned and that such 
breathing-focused exercises can yield measurable benefits in decreasing physiological 
(e.g., lung capacity, swallowing safety) and psycho-emotional (e.g., quality of life) 
burden. 
Additionally, research has been carried out to understand the impact of breathing 
on wellness more broadly. Past research suggests that respiration and emotion 
bidirectionally influence each other (Boiten et al., 1994; Ley, 1999; Philippot et al., 
2002). For example, breathing interventions have been demonstrated to enhance emotion 
regulation in healthy individuals (Arch & Craske, 2006). Sixty healthy undergraduate and 
graduate students responded to the picture slides from the International Affective Picture 
System during focused breathing and when they were told to “let their minds wander”. 
Participants who underwent focused breathing exhibited consistent positive responses 
whereas the groups induced to have unfocused attention and worry demonstrated more 
negative responses. Breathing interventions have also been reported to normalize 
parasympathetic activities in anxious populations (Kaushik et al., 2006). One hundred 
individuals with essential hypertension with and without anti-hypertensive drugs 
participated in the study. They underwent trainings on mental relaxation (i.e., thinking of 
something pleasant) and slow breathing (i.e., taking slow and deep breaths with focus on 
inspirations and expirations). It was reported that both techniques lead to a reduction in 
systolic blood pressure, diastolic blood pressure, heart rate, and respiratory rate; however, 
slow breathing resulted in a significant decrease in all-mentioned areas, as compared to 
other approaches. Therefore, controlled breathing can be effective in normalizing cardio-




populations with experimentally-induced anxiety (Sakakibara & Hayano, 1996). To 
understand the effect of controlled slowed respiration on cardiac parasympathetic 
response to threat (i.e., an anticipated electric shock), thirty healthy college students were 
randomly assigned to slow, fast, and non-paced breathing groups. Results suggested that 
cardiac parasympathetic withdrawal response to threat is reduced with slowed breathing. 
Breathing, while an act of survival, also provides a mean to regulate physiological (e.g., 
blood pressure, bodily response to threat) and psycho-emotional (e.g., remaining positive, 
regulating emotions) aspects of life. 
Further, the act of breathing can be either voluntary or involuntary, or a 
combination of both. It involves complex feedback mechanisms in the automatic visceral 
networks, brainstem nuclei, limbic system, cortical areas, and neuroendocrine system 
(Brown & Gerbarg, 2005a). Yogic breathing adjusts imbalances in the autonomic 
nervous system and, by extension, influences mental and physical status (Sovik, 2000) as 
voluntary controlled breathing can influence autonomic nervous system functions (e.g., 
heart rate variability, cardiac vagal tone, chemoreflex sensitivity, baroreflex, and control 
nervous system) (Brown & Gerbarg, 2005a).  
In summary, while past research theoretically supports the benefits of breathwork 
and/or meditation for individuals with COPD, their limitations include non-standardized 
interventions, long interventions and time commitments, and lack of prior research 
support for the programs themselves. An evidenced-based program that is taught per a 
manual can enhance the treatment fidelity. Additionally, in a population like COPD, 
where treatment adherence can pose an issue, a shorter program may improve 




for individuals with dysphagia. As comorbid anxiety and depression are common in 
COPD-related dysphagia, trained breathwork may help regulate emotions to remain 
positive and decrease physiological burden (e.g., as measured by blood pressure, bodily 
response to threat, lung capacity). Therefore, taken together, utilizing breath-based 
meditation that is short in duration and delivered according to a manual may be a viable 
approach to address the physiological and psycho-emotional consequences of COPD and 
COPD-related dysphagia by directly targeting anxiety and depression, while also 
addressing pulmonary physiology through structured breathing. 
Sudarshan Kriya Yoga 
Sudarshan Kriya Yoga (SKY) is a cyclical controlled breath meditation by the Art 
of Living Foundation (Brown & Gerbarg, 2005a, 2005b). SKY is nine-hour program that 
is delivered across three days according to a manual. The manual details the flow of the 
program, precautions to take, and suggested as-needed alterations. The program is 
facilitated by teachers, who have received over 1000 hours of practicing and teacher 
training in meditation and breathing. They are certified to modify the instruction of the 
techniques depending on the medical conditions of the participants. 
SKY is composed of four components: ujjayi, bhastrika, “Om”, and Sudarshan 
Kriya. The victorious breath (ujjayi) is done in three stages of arm positions at a 
rhythmical and timed pace. The bellows breath (bhastrika) is completed with forceful 
inhalations and exhalations in a specific cycle. The sound “Om” is said three times. 
Sudarshan Kriya is carried in cyclical rhythms of three different rates.  
Over 100 independent studies across different populations and age groups have 




physiological (body) and psycho-emotional well-being (mind) (e.g., Seppälä et al., 2014; 
Sharma et al., 2017). Of relevance to the current proposal, a number of studies have 
explored the impact of SKY on pulmonary and anxiety/depression-related measures. For 
example, in one research study, 100 healthy participants completed the SKY program and 
cardiovascular and respiratory outcomes were collected (Kale et al., 2016). Post-
intervention, participants presented with decreased cardiovascular markers (i.e., pulse 
rate and systolic and diastolic blood pressure) as well as increased respiratory measures 
(i.e., forced vital capacity, FVC; forced expiratory volume in one second, FEV1; peak 
expiratory flow rate, PEFR; breath holding time) when compared to the control group. 
Another study that involved 63 healthy individuals also showed improved FEV1, FVC, 
and PEFR after SKY (Bodi et al., 2008). Based on the normative data, the authors 
suggested that SKY is an appropriate complementary treatment to pre-existing medical 
management for individuals with obstructive airway disease. Improved cardiorespiratory 
parameters were also confirmed in a study of 30 healthy individuals, where decreased 
heart rate, systolic and diastolic blood pressures, and respiratory rate was reported 
(Somwanshi et al., 2013). Such physiological improvement following SKY has also been 
noted in U.S. military veterans with posttraumatic stress disorder symptoms (Seppälä et 
al., 2014). Reductions in respiratory rate were reported in the intervention group (n = 11), 
but not in the waitlist control group (n = 10). Further, past research investigating SKY on 
the lung function of healthy individuals has suggested exploring the impacts of SKY on 
obstructive airway disease (e.g., asthmatics) as a future direction (Bodi et al., 2008). 
In terms of psycho-emotional well-being, SKY has also demonstrated promise. A 




response to anti-depressants participated in the SKY intervention (Sharma et al., 2017). 
No adverse events were reported in the intervention group (n = 13). Results showed 
improvements on the Hamilton Depression Rating Scale, the Beck Depression Inventory, 
and the Beck Anxiety Inventory in the SKY group when compared to the waitlist control. 
In a recent randomized control trial, SKY was compared to the Foundations of Emotional 
Intelligence (EI) and Mindfulness-Based Stress Reduction (MBSR) programs in a group 
of university students (Seppälä et al., 2020). Four groups were compared: SKY (n = 29), 
EI (n = 21), MBSR (n = 34), and non-intervention control (n = 47). SKY exhibited the 
greatest positive impact across six outcomes: depression, stress, mental health, 
mindfulness, positive affect, and social connectedness. EI showed benefit in mindfulness, 
and MBSR revealed no change as compared to the control group and when controlling 
for variance of baseline measurements and multiple comparisons. Similarly, SKY was 
compared to the Wisdom on Wellness (WOW) program across 69 undergraduate and 
graduate students in a university setting (Goldstein et al., 2020). Both programs showed 
similar ratings on workshop evaluations and retention rates. However, SKY demonstrated 
greater improvements on perceived stress, sleep, social connectedness, distress, anxiety, 
depression, conscientiousness, self-esteem, and life satisfaction.  
Literature on SKY has thus far suggested improved respiratory-related functions 
among healthy individuals and psycho-emotional outcomes in healthy and otherwise 
affected groups. These positive outcomes can potentially translate to individuals with 
COPD; however, no literature to date has investigated the acceptability and effectiveness 
in this population. Previous research has indicated that modifications can be made to 




irritation (Brown & Gerbarg, 2005b). Further, SKY is a relatively short program in 
length, compared to other programs discussed earlier. In a population where adherence is 
an issue, a short program may yield improved compliance and, therefore, improved 
outcomes. Additionally, SKY is a program that is delivered per a manual when other 
literature discussed prior used approaches from different sources. As comorbid anxiety 
and depression are common among individuals with COPD and dysphagia, SKY may be 
a particularly valuable intervention to comprehensively address these diseases from a 
mind-body-breath framework. 
Statement of Purpose and Research Questions 
 The purpose of the present study was to investigate the acceptability and 
feasibility of the SKY breathing-based intervention among individuals with COPD as 
well as to preliminarily explore the impact of this intervention on self-reported 
pulmonary burden (body), oral intake experience (body-mind), and overall well-being 
(mind). This study utilizes a comprehensive lens and offers a unique direction in 
swallowing and COPD research by providing new insights into the feasibility and 
acceptability of an approach that moves beyond impairment-level focus to better address 
the whole person, taking the interconnectedness of the mind, body, and breath into 
consideration. 
 This study specifically investigated the following questions: 
1.  What is the acceptability and feasibility of SKY among individuals with COPD?  
Hypothesis: Nil (phenomenon will be based on participants’ narratives).   
2. Is there a functional relation between SKY and improved consequences of COPD 




a. Is there a functional relation between SKY and dyspnea perceptions (i.e., 
work of breathing, WOB; shortness of breath, SOB; dyspnea-related 
distress, DD; and dyspnea-related anxiety, DA)? 
b. Is there a functional relation between SKY and increased oral intake 
enjoyment? 
c. Is there a functional relation between SKY and decreased oral intake 
difficulty? 
Hypothesis: It is anticipated that the magnitude of dyspnea-related perceptions 






















Sixteen individuals with COPD were recruited. Inclusion criteria were: fluency in 
English, functional cognitive-linguistic skills, and a physician’s diagnosis of COPD. Per 
the recommendations of the SKY Research Committee, all participants were between 30 
and 75 years of age. Those with uncontrolled hypertension, neurological disorders, 
tracheostomy tubes, naso-gastric feeding tubes, active pulmonary infections, exacerbated 
COPD, COPD requiring oxygen support during the day, cardiac ischemia, major 
psychiatric disorders (e.g., schizophrenia, schizoaffective, bipolar), seizure disorders, 
current/recent pregnancy, recent major surgery (within the past 8 weeks), or congestive 
heart failure were excluded. The study was open to individuals with a range of COPD 
severity, and severity was not used as inclusion or exclusion criteria. No inclusion criteria 
related to dysphagia status were used. Additionally, participants were required to have 
stable internet access and a device to connect to Zoom video and audio features. They 
were instructed to continue their medical routine as usual. 
Participants were recruited via word-of-mouth, flyers posted in healthcare-
associated settings (e.g., physician offices) and public/community social media platforms 
(e.g., Facebook), and email through ResearchMatch. Since this study was conducted 
virtually, we welcomed participants from anywhere in the United States of America. 
Additionally, in order to profile the COPD severity of each participant, we attempted to 




participants; when available, participants shared their most recent pulmonary function 
test report with the research team.     
Participants residing in the same time zone were assigned to the same intervention 
group (i.e., Pacific, Central, and Eastern). These groups were then randomized to 
determine the order of the receipt of intervention, with the start of intervention staggered 
across the three groups. Two individuals could not make it to their assigned group 
intervention timing; therefore, they were presented with the timing of the next group.  
Of the 16 initial participants who were consented and enrolled in the study, six 
did not continue into the start of the intervention (three had schedule conflicts with the 
intervention timings and decided to discontinue; the other three did not provide a reason). 
One dropped out of the intervention on the second day due lack of interest. Thus, a total 
of nine participants completed the study. Demographic information for these nine 
participants is displayed in Table 1, with their most recent pulmonary function test results 
from their respective clinics in Table 2. Participants’ COPD severity was determined 


























WA 1 Ohio 70 Male White/Non-
Hispanic 
Hypertension, status post 2/3 of 









Peripheral artery disease with 
history of stent placements, 
enlarged prostate, post-
traumatic stress disorder, rectal 
dysfunction 
Quit smoking NA 
RT 1 Ohio 71 Male White/Non-
Hispanic 
Skin cancer, hypertension, 
glaucoma, neuropathy of feet, 
tinnitus, neck/back issues 
Quit smoking  Yes, when 
weather 
allows 








GG 2 Oregon 68 Female White/Non-
Hispanic 
Celiac, melanomas, irritable 






SS 2 Ohio 59 Female White/Non-
Hispanic 
Recurrent major depression Quit smoking Yes 
JK 2 Illinois 69 Male White/Non-
Hispanic 
Prostate cancer, history of 
pulmonary embolism, shoulder 
and leg operations 
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PS 3 Texas 57 Female White/Non-
Hispanic 
NA Quit smoking Yes 
RF 3 Florida 61 Male White/Non-
Hispanic 
Sinus infections, vocal cord 
damage from house fire 
No, history 
of being in 
house fire 
Yes 


























Severity Based on American 
Thoracic Society Grades 
(Johnson & Theurer, 2014) 
WA NA NA NA NA NA 
RK 105 64 44 NHANES III – Caucasian Moderate 
RT 74 53 53 NHANES – Caucasian Moderately severe 
JL 81 45 46 Knudson Severe 
GG  90 89 65 Eigen/Bieler  Mild  
SS NA NA NA NA NA 
JK  93 78 62 NHANES III – Caucasian Mild 
PS 54 22 32 NHANES III Very severe 
RF 60 47 59 NHANES – Caucasian Severe 
Note. %Ref = percentage of reference value; FEV1 = forced expiratory volume in one second;  



















Study Design  
This study used a mixed-methods design, involving qualitative and single-case 
methodologies. These methodologies allowed for a broader investigation of the feasibility 
and potential utility of a mind-body-breath-based intervention for individuals with 
COPD. A comprehensive lens focusing on both the physiological and the psycho-
emotional aspects of dyspnea was adapted. To control for potential effects of the season, 
all of the intervention sessions and single-case data collection timepoints were completed 
in the same month. Additional details for each method are provided below. 
 Qualitative phenomenology aims to capture complete and accurate descriptions of 
particular human experiences and emotions (Groenewald, 2004). Since the acceptability 
and feasibility of SKY among individuals with COPD has not yet been explored, this 
approach was appropriate to employ in order to gain a more complete description of 
participants’ experiences with SKY. Primary sources of data included semi-structured 
interviews and field notes.   
 Single-case methodology is utilized to document functional relations between 
independent and dependent variables. It is a rigorous experimental approach to involve a 
small number of participants, observing them over time, and it allows each participant to 
provide their own experimental control (Horner et al., 2005). Further, single-case 
methodology is ideal for establishing the effects of a new intervention in real-life settings 
before attempting them on a large scale, such as in a randomized control trial (Byiers et 
al., 2012; Horner et al., 2005; Lobo et al., 2017). Since SKY has not been studied with 
individuals with COPD, single-case methodology was employed to explore if there is a 






and oral intake difficulty. This design allowed for understanding of any functional 
changes in the participants’ functional respiratory status after the intervention.  
Lastly, quantitative information about anxiety and depression, affect, swallowing 
status, and COPD were collected to further describe the participant population before and 
after the intervention. Data were collected through self-report questionnaires including 
the Hospital Anxiety and Depression Scale, Positive and Negative Affect Schedule, 
COPD Assessment Test, Eating Assessment Tool-10, and Dysphagia Handicap Index.  
Procedure and Analysis  
Procedures 
This research was conducted with approval from the University of Oregon 
Institutional Review Board and The Art of Living SKY research committee. Table 3 
outlines the procedures and data collection process across all study timepoints; a detailed 
description of each follows. 
Table 3 
Procedures and Data Collection Schedule 
Time Task 
Time 0 
(≥5 days pre-SKY) 
a. Screen participants 
b. Consent 
c. Assign to groups 
d. Begin data-collection for single case 
e. Collect questionnaires 
Time 1 
(5 days pre-SKY) 
a. Teach victorious breath 




b. End data-collection for single case 
c. Collect questionnaires 
Time 3 
(10 weeks post-SKY) 






Individuals who were interested in participating in the study were contacted by 
the principal investigator (PI). They were screened on the phone to determine eligibility 
for study participation. For participants that met the eligibility criteria and chose to enroll 
in the study, the informed consent process took place via Zoom. Following study 
enrollment, all of the participants were divided into their time zone groups, and the 
groups were randomized to determine the order of receipt of intervention. Two 
individuals had a schedule conflict with their group intervention timings; they were both 
allowed to join the next group.  
Below, I first describe the SKY intervention. Then I discuss the specific data 
collection procedures associated with the qualitative and single-case portions of the 
study.  
Intervention. SKY is an evidenced-based breath-based meditation program, 
offered by the Art of Living Foundation. It has previously been shown to result in 
improvements in mental and physiological well-being, including cardio-pulmonary 
functioning, in populations other than COPD (Anju et al., 2015; Brown & Gerbarg, 2002; 
Ghahremani et al., 2013; Seppälä et al., 2014; Sharma et al., 2015). The SKY training is a 
nine-hour group program that takes place across three days (three hours each day), 
consisting of victorious breathing (ujjayi), bellow breathing (bhastrika), “Om”, and 
Sudarshan Kriya. Victorious breath is done via light constriction of the laryngeal 
muscles. Bellow breath is done via rapid inhalation and forceful exhalation. “Om” is said 
thrice. Sudarshan Kriya uses cyclical and rhythmic breathing patterns (Brown & Gerbarg, 
2005a). Participants in the current study were instructed to complete the breathing 
techniques more gently at first to reduce airway irritation, as has been suggested 
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previously in the literature (Brown & Gerbarg, 2005b); additional breathing 
modifications were made as needed, at least in the beginning of the intervention, to allow 
participants time to acclimate to conscious breathing.  
A trained and experienced SKY instructor, who was blinded to the study 
hypotheses, facilitated the program per the SKY manual. During the intervention phase, 
the SKY instructor provided visual (e.g., demonstration) and auditory (e.g., verbal 
instructions) cues to ensure adequate learning of the SKY. She also reviewed breathing 
techniques every session. Finally, a trained data collector was present throughout the 
three days of intervention for each group to document intervention fidelity in addition to 
the instructor (further details below). The intervention was completed via 
teleconferencing. The first and the second day of SKY mainly focused on breathwork; the 
participants practiced the home practice on the third day. The home practice consists of 
victorious breathing, bellow breathing, and a short version of Sudarshan Kriya. The PI 
was present and supported the SKY instructor as needed.   
Five days prior to the start of the intervention (Time 1), participants learned a 
component of SKY (i.e., victorious breathing) via Zoom in their respective groups. The 
purpose of this initial training was to help participants get acclimated to the controlled 
and trained breathing technique. Generally, this instruction was provided in a group 
setting by the SKY instructor for one hour over a single session. The exception was made 
for one participant (GG), who could not make it to the scheduled session and had a 1:1 
session with the SKY instructor instead. Participants were instructed to practice the 
victorious breathing daily until the start of the intervention. 
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Intervention fidelity was assessed through a number of different mechanisms. 
First, for each participant, the SKY instructor documented whether she taught each 
component (i.e., self-rating) and whether the participants were able to correctly 
demonstrate each component each training day. Second, a trained data collector, blinded 
to the study hypotheses, observed the sessions live and completed a fidelity checklist, 
rating whether all components were covered by the instructor and whether the 
participants demonstrated the components accurately. This collector was present 
throughout the intervention (i.e., fidelity frequency of 100%). The PI kept an attendance 
log for the entirety of the research program. 
Upon completion of the three-day intervention, participants were instructed to 
continue to practice daily for the next ten weeks. Additionally, participants were 
instructed to attend weekly group follow-up booster sessions, where SKY was completed 
in the group setting. The weekly ~60-minute follow-up sessions continued for 
approximately 10 weeks, allowing participants to supplement their daily individual 
practice with a group via Zoom. Participants were encouraged to attend 75% of the 
follow-up booster sessions. A follow-up attendance log was also kept. 
Qualitative Data Collection. The PI interviewed each participant individually 
between five and thirteen days after the completion of the three-day SKY training (Time 
2 in Table 3). The PI presented brief, open-ended questions to understand the 
participants’ perceptions related to their acceptability and feasibility of the SKY training. 
The PI did not know 8/9 of the research participants before the study. According to both 
the PI and the data coders during the analysis process, the interview with the familiar 
participant followed the standard procedure and no differences were noted. Further, the 
 
    
 
55
PI is a volunteer SKY instructor. To reduce the introduction of bias and limit the potential 
for the PI’s relationship with SKY from impacting the data analysis process, bracketing 
was utilized to allow the participant narratives and experiences to surface from their own 
perspective (e.g., interview questions were directed to the participants’ experiences and 
feelings, the researcher “bracketed” her own preconceptions) (Groenewald, 2004) and 
additional members of the research team were involved in the data analysis process, as 
will be described below.  
The use of phenomenological qualitative methodology allowed the participants’ 
voices to reveal their experience of the SKY intervention (Groenewald, 2004). For a 
complete list of questions, please refer to Table 4. These questions served as guiding 
questions — follow-up probes were used depending on participants’ responses. The semi-
structured interviews took place online via Zoom. Each interview was conducted by the 
PI and lasted about 30 – 50 minutes. Video and audio recordings were completed. Field 
notes were also taken to serve as an additional source of primary data.  
Table 4 
Interview Questions     
Qualitative interview questions — adapted from Linville et al. (2018) 
What has been your experience with SKY? What are strengths and weaknesses about 
it? 
What are some of the changes that you have noticed in your daily activities that you 
think may have something to do with your participation in SKY? 
What are some of the changes that you have noticed in your oral intake that you think 
may have something to do with your participation in SKY? 
What are some of the changes that you have noticed in your social life that you think 
may have something to do with your participation in SKY? 
What are some of the changes that you have noticed in your sleep quality that you 
think may have something to do with your participation in SKY? 
What are the best parts of SKY from your perspective? What changes would you 
recommend to SKY? 
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Table 4 (continued). 
Have you noticed any differences in the way you think about your physical activities, 
oral intake, and social life since your participation in SKY? 
What factors might make it difficult for you to take what you have learned in SKY and 
use it in your day-to-day life? 
Have you noticed that sky has affected your emotions? If so, how has SKY impacted 
your emotions?  
Have you noticed that sky has affected your breathings? If so, how has SKY impacted 
your breathing? 
What are some reasons you might or might not recommend SKY to someone else with 
COPD? 
 
Single-Case Data Collection. A single-case, multiple baseline design across 
participants was utilized for this study. Participants received the SKY intervention at 
three different points in time, and the order in which they received the intervention was 
determined via randomization. Baseline data collection began simultaneously for all 
participants across all groups (Time 0 in Table 3), and at least five baseline data points 
were collected before participants received the SKY intervention. On each day of 
baseline data collection, a Modified Borg scale and a six-point Likert scale were emailed 
to each participant to use to rate the target questions/outcomes of interest. The former 
was used for participants to rate different dyspnea perceptions, including work of 
breathing (WOB), shortness of breath (SOB), dyspnea-related distress (DD), and 
dyspnea-related anxiety (DA), and the latter was used to rate mealtime enjoyment and 
mealtime difficulty. Given the goal of exploring eating-related dyspnea and the mealtime 
experience, prior to data collection commencing, the PI asked the participants about their 
typical dinner schedule in order to time data collection appropriately. The PI and research 
team called the participants at the agreed time (i.e., right after their meal) and recorded 
the participants’ ratings of perceived dyspnea and mealtime enjoyment and difficulty. 
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This process was continued throughout the baseline and intervention phases, and ended 
six days after the end of the intervention for the third group (Time 2 in Table 3). 
 Once a baseline had been established for the first group (i.e., at least five stable 
baseline data points or worsening responses) the SKY intervention was implemented. Via 
a staggered multiple baseline design, the second group of participants remained in 
baseline and did not receive SKY until the first group’s intervention data points 
demonstrated improvement on their responses. Once the second group received SKY, the 
same protocol of staggered implementation was applied to the third group.  
Four outcomes were aimed to measure different dyspnea perceptions. They were: 
WOB, SOB, DD, and DA. After dinner each evening, across Time 0, Time 1, 
Intervention, and Time 2, participants were asked to respond to the following questions 
based on how they were feeling right now, at that moment in time: "How hard are you 
working to breathe; that is, how much effort is it taking you to breathe?" (WOB); "How 
short of breath are you; that is, how intense or severe is your shortness of breath?" (SOB); 
"How distressing is your shortness of breath to you; that is, how bothersome or upsetting 
is your shortness of breath to you?" (DD); and "How anxious about your shortness of 
breath are you; that is, how nervous or apprehensive about your shortness of breath are 
you?" (DA) (Carrieri-Kohlman et al., 1996). Participants provided their rating for each of 
the four dyspnea perceptions individually using the Modified Borg Scale (Burdon et al., 
1982) (see Table 5 below). 
Additionally, following the same data collection schedule (across Time 0, Time 1, 
Intervention, and Time 2), the participants also responded to the questions “How 
enjoyable was your meal experience?” and “How difficult was eating during your meal?” 
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using a six-point Likert scale (Table 6 below). Likert scales are often used in the social 
sciences to measure individual traits, such as self-efficacy and self-perception (Boone Jr. 
& Boone, 2017; Croasmun & Ostrom, 2011). 
Table 5 
Modified Borg Scale 
0 Nothing at all (just noticeable) 
0.5 Very very slight 
1 Very slight 
2 Slight 
3 Moderate 
4 Somewhat severe 
5 Severe 
6  
7 Very severe 
8  




Six-point Likert Scale 
0 Not at all  
1 Very slightly 
2 Somewhat 
3 Moderate 
4 Very much 
5 Maximal 
 
Descriptive Data. Data on self-reported anxiety, depression, overall affect, 
COPD experience, and swallowing-related quality of life were collected online via a 
single Qualtrics survey from all participants. Participants completed the survey at Time 0, 
Time 2, and Time 3. Namely, these data were collected about five days before SKY 
(Time 0), after SKY (Time 2), and 10 weeks after SKY (Time 3). The link to the 
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Qualtrics survey was shared via email so that participants were able to fill it out 
independently. The four outcome tools are discussed below. 
The Hospital Anxiety and Depression Scale (HADS) is validated and used to 
reliably determine degree of clinical anxiety and depression for individuals with physical 
health problems (Zigmond & Snaith, 1983). It is a self-administered questionnaire that 
takes approximately 5-10 minutes to complete. There are seven items on anxiety and 
another seven on depression. Each item on the questionnaire is scored from 0 to 3. Total 
scores range from 0 to 42. Lower scores mean less presence of anxiety and depression. 
HADS 0-7 suggests normal, 8-10 suggests presence of respective state or borderline base, 
11-21 suggests presence of case (Snaith, 2003). For individuals with COPD, ~1.5 points 
or ~20% change from baseline can correspond to the minimal important difference of 
HADS in interpreting the importance of treatment effects (Puhan et al., 2008). 
The Positive and Negative Affect Schedule (PANAS) is a brief, easy-to-
administer, valid and reliable tool to measure positive and negative affect (Watson et al., 
1988). Positive affect is defined as a person feeling enthusiastic, active, and alert; 
negative affect is defined as a person feeling anger, contempt, disgust, guilt, fear, and 
nervousness. This 5-10-minute self-administered measure can be used by everybody 
regardless of health status. There are 20 items; each item on the questionnaire is scored 
from 1 to 5. Total scores range from 20 to 100: positive affect scores can range from 10 
to 50, with higher scores representing higher levels of positive affect; negative affect 
scores can range from 10 to 50, with lower scores representing lower levels of negative 
affect.  
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The COPD Assessment Test (CAT) is a validated assessment for individuals with 
COPD (Jones et al., 2009). This eight-item, self-reported questionnaire assesses the 
impact of COPD on health status. Each item is associated with a six-point scale (e.g., I’m 
very happy 0 — 5 I’m very sad). A total score is obtained by summing the responses 
across all eight items. Each item on the questionnaire is scored from 0 to 5, and total 
scores range from 0 to 40. Higher scores represent worse health status. The CAT user 
guide (http://www.catestonline.org) categorizes scores into severity bands: upper limit of 
normal in healthy non-smokers (score 0 to 5), low impact (6 to 9), medium impact (10 to 
20), high impact (21 to 30), and very high impact (31 to 40). GOLD recommends a cutoff 
score of 10 to measure the presence of a symptomatic impact of COPD (Jones et al., 
2011; Tsiligianni et al., 2016). CAT, as a complementary clinical assessment tool, can be 
used to predict COPD exacerbation, health status deterioration, depression, and mortality 
(Karloh et al., 2016). 
The Eating Assessment Tool (EAT-10) is validated and targets individuals with 
dysphagia (Belafsky et al., 2008). It is a patient-reported outcome tool that was designed 
to evaluate dysphagia-related symptom severity, quality of life, and treatment outcome. 
There is a total of ten questions, and total administration time is less than two minutes. 
Each item on the questionnaire is scored from 0 (no problem) to 4 (severe problem), 
yielding total available scores ranging from 0 to 40. Higher scores indicate increased 
severity. For the EAT-10, a cut-off value of 9 has been shown to predict aspiration in 
92% of adults with stable COPD (Regan et al., 2017), and an EAT-10 score of ≥ 3 can 






The Dysphagia Handicap Index (DHI) is validated and targets individuals with 
dysphagia as a result of a variety of medical diagnoses (Silbergleit et al., 2012). It is a 
patient-reported outcomes tool that measures physical, functional, and emotional aspects 
of dysphagia. It is a 25-item, self-administered questionnaire that takes 5-10 minutes to 
complete, and total scores range from 25 to 175. The first section requires participants to 
answer ‘never’, ‘sometimes’, ‘always’ to each statement and then self-rate their perceived 
dysphagia severity from 1 to 7 with 1 being normal and 7 being severe. Lower scores 
indicate less perceived impact from dysphagia. The last section is a self-rating of 
swallowing severity.   
Data Analysis  
 Qualitative. Qualitative methodology helps to better understand a phenomenon 
within certain groups of interest (Wu et al., 2016). It allows participants’ words to inform 
model and theory development in exploring intervention outcomes, rather than the 
analysis being guided by pre-existing researcher hypotheses (de Visser et al., 2015; Hess 
& Straub, 2011). Phenomenological qualitative methodology, in particular, allows the 
participants’ voices to speak, shaping the overall narrative of the experience in the 
intervention (Groenewald, 2004; Linville et al., 2018). The data analysis methods for the 
current study were adopted from Groenewald (2004) and Linville and colleagues (2018).  
First, the auto-generated interview transcripts (generated through the Zoom 
software) were manually checked and updated by the research team as needed. Further, if 
any parts of the transcript did not make sense semantically during the subsequent coding 
process, the transcript was cross-checked again against the recording. These verbatim 
transcripts served as a primary source of data along with the field notes as described 
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above. Data analysis began with the transcripts and notes being read closely to identify 
the participants’ statements of meaning related to their experience with SKY by the PI 
and three additional coders. The four-person research team completed the coding process 
while being careful not to impose interpretation, or outside meaning, on the participants’ 
words, particularly in the first stages of coding, so that the overall essence of each 
transcript could be retained. Each transcript was ultimately independently coded by two 
individuals. Common categories across interviews as well as individual coding variations 
were recorded, leading to the thematic building (vertical analysis process). The reported 
findings were based on the final themes and the sub-themes that emerged across the 
coding process. Questions regarding the coding process were addressed at weekly 
meetings; reconciliation of the discrepancies in data coding took place at these meetings 
across coders. 
The trustworthiness of the findings was ensured through multiple steps. First, one 
of the dissertation committee members (i.e., DL) acted as an external auditor throughout 
the entire research as outlined by the Robert Wood Johnson Foundation 
(http://www.qualres.org/HomeExte-3704.html). Second, the research team attended data 
analysis training and debriefing sessions frequently. This was to ensure research 
effectiveness and that the emerging themes and categories remained truthful to the data. 
Third, bracketing was employed to avoid personal preconceptions and biases from 
entering into the data analysis. 
Single Case. The single-case design data were first analyzed through visual 
analysis, a traditional approach (Horner et al., 2005). Visual analysis was completed for 






variability, immediacy effect, overlap, and consistency of data with and across phases 
was observed. Data visualization was further augmented by two quantitative analyses to 
explore the effect size of the intervention between the baseline and the SKY phases. First, 
the Tau-U statistic was calculated to generate an effect size of the intervention. Tau-U, a 
reliable estimate of effect size, integrates nonoverlap between the baseline and the 
intervention phases while controlling for monotonic trend within the data (Parker et al., 
2011). The Tau-U analyses were completed using a publicly available calculator at 
https://jepusto.shinyapps.io/SCD-effect-sizes/. The interpretation of the Tau-U scores 
used the following values: .65 or lower: weak or small effect; .66 to .92: medium to high 
effect; and .93 to 1: large or strong effect (Parker et al., 2011). Second, log response 
ratios (LRR) were utilized to describe the magnitude of the functional relations between 
the behavioral measures by quantifying functional relations of proportionate change 
between phases in the level of the outcome (Pustejovsky, 2018). The LRR, a general 
metric of an effect size index, compares two mean levels. Direction of improvement is 
indicated as LRR-d for decrease (in the measures of WOB, SOB, DD, DA, and mealtime 
difficulty) or LRR-i for increase (in the measure of mealtime enjoyment) based on the 
questions wording and the scales used. Confidence level was set for .95. The percentage 
change metric helps conceptualize the effect size of treatment impacts. The LRR 
calculations were completed using the calculator available at 
https://jepusto.shinyapps.io/SCD-effect-sizes/.  
Descriptive Data. Raw scores were calculated according to the standard 
procedures associated with each questionnaire and presented quantitatively for the 
HADS, PANAS, CAT, EAT-10, and DHI. Additionally, using descriptive statistics, both 
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the overall patterns for the entire group as well as the individual patterns of change across 










 This chapter presents the results of the analyses conducted to answer the two 
research questions. Results include: (a) qualitative analyses using phenomenological 
methodology of the interviews for understanding the feasibility and the acceptability of 
SKY; and (b) visualization of the data collected during the single-case multiple baseline 
design for measures of perceived dyspnea and mealtime experience and the statistical 
analyses of the intervention effects. 
Intervention Fidelity and Adherence 
Important to interpreting the results of the intervention, first I present the fidelity- 
and treatment-adherence-related data (see Tables 7 – 11). All participants attended all 
three days of the SKY intervention (see Table 7). There was excellent agreement between 
the SKY instructor’s self-rating and trained data collector’s ratings that each component 
of SKY was covered in the training (see Tables 8 and 10) and that each participant 
accurately demonstrated every component of SKY across the training sessions (see 
Tables 9 and 11). At the 10-week follow-up survey, a majority of the participants 
reported continuing with the SKY home practice after the intervention: 11.11% (1/9) 
practiced every day, 55.56% (5/9) practiced 4 – 6 days a week, and 33.33% (3/9) 
practiced 1 – 3 days a week. Additionally, 44.44% (4/9) attended at least six of the 
weekly follow-up sessions for intervention, 44.44% (4/9) attended at least one but less 
than five, and 11/11% (1/9) attended none (see Table 12 for post-intervention adherence). 









Participant Attendance  
Participant SKY Attendance 
Day 1 Day 2 Day 3 
WA Yes Yes Yes 
RK Yes Yes Yes 
RT Yes Yes Yes 
JL Yes Yes Yes 
GG Yes Yes Yes 
JK Yes Yes Yes 
SS Yes Yes Yes 
PS Yes Yes Yes 
RF Yes Yes Yes 
 
Table 8 
SKY Instructor Self-rating Whether Each Component of SKY Was Covered 
 Group 1 Group 2 Group 3 
Ujjayi Yes Yes Yes 
Bhastrika Yes Yes Yes 
“Om” Yes Yes Yes 
Sudarshan Kriya Yes Yes Yes 
 
Table 9 
SKY Instructor Rating Whether Each Participant Demonstrated the SKY Components 
Accurately 
Participant SKY Components 
Ujjayi Bhastrika “Om” Sudarshan Kriya 
WA Yes Yes Yes Yes 
RK Yes Yes Yes Yes 
RT Yes Yes Yes Yes 
JL Yes Yes Yes Yes 
GG Yes Yes Yes Yes 
JK Yes Yes Yes Yes 
SS Yes Yes Yes Yes 
PS Yes Yes Yes Yes 
RF Yes Yes Yes Yes 
 




Data Collector Rating Whether Each Component of SKY Was Covered by SKY Instructor 
 Group 1 Group 2 Group 3 
Ujjayi Yes Yes Yes 
Bhastrika Yes Yes Yes 
“Om” Yes Yes Yes 
Sudarshan Kriya Yes Yes Yes 
 
Table 11 
Data Collector Rating Whether Each Participant Demonstrated the SKY Components 
Accurately 
Participant SKY Components 
Ujjayi Bhastrika “Om” Sudarshan Kriya 
WA Yes Yes Yes Yes 
RK Yes Yes Yes Yes 
RT Yes Yes Yes Yes 
JL Yes Yes Yes Yes 
GG Yes Yes Yes Yes 
JK Yes Yes Yes Yes 
SS Yes Yes Yes Yes 
PS Yes Yes Yes Yes 
RF Yes Yes Yes Yes 
Table 12 
Self-reported SKY Home Practice Frequency (10 weeks Post-Intervention) and Optional 
Weekly Follow-up Session Attendance  
Participant Self-reported daily SKY home 
practice frequency 
Optional weekly post-intervention 
follow-up sessions 
(Sessions attended/10 weeks) 
WA 4-6 days a week 3/10 
RK 4-6 days a week 8/10 
RT 4-6 days a week 6/10 
JL 4-6 days a week 2/10 
GG 1-3 days a week 7/10 
JK 4-6 days a week 7/10 
SS 1-3 days a week 0/10 
PS 1-3 days a week 1/10 
RF Every day 4/10 
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Acceptability and Feasibility of SKY Among Individuals with COPD 
 The first research question was aimed at understanding the acceptability and 
feasibility of SKY in our study population. As emerging from the interviews, a central 
phenomenon of ‘lessened COPD-related mind-body-breath burden after SKY’ developed. 
Overall, the qualitative data revealed that COPD’s physiological manifestations and 
psycho-emotional consequences can be improved via SKY. Specifically, SKY appeared 
to play a vital role in enhancing aspects of the mind, body, and breath as well as in 
alleviating or minimizing the cyclical impacts of COPD’s physiological and psycho-
emotional effects. Significantly, participants not only acknowledged reductions in 
COPD-specific symptoms, but also consequently described how the reductions in 
symptoms helped enhance other aspects of life – and vice versa. Participants shared: 
Absolutely, I think I think [SKY] affects everything, that maybe those emotional 
manifestations I think can be attributed to many different activities of daily living, 
and if you can alleviate that or slow it down or be aware of it in a different way 
then certainly that's going to help coughing, breathing, awareness, movement. All 
those things. (JL) 
[SKY] could teach you to be able to relax a little bit better when you're feeling 
shortness of breath coming on because that just, you know, it kind of builds on 
itself so if you're able to relax a little bit and to breathe more- more deeply and all. 
(GG) 
 
That [SKY] is helpful to deal with those [negative] feelings, with the shortness of 
breath and the feelings and able to manage those kinds of feelings. (SS) 
 
 Three interrelated categorical themes tied to the overall concept of lessened 
COPD-related mind-body-breath burden surfaced from the qualitative interview data that 
illustrated the components involved in living with COPD: (a) mind; (b) body; and (c) 
breath. Figure 3 provides a schematic representation of these themes. The themes are 







Figure 3. Lessened COPD-related mind-body-breath burden after SKY  
 
Firstly, participants reported psycho-emotional changes following the SKY 
intervention, or changes related to the mind. Many indicated feeling “more relaxed” 
(WA) that ultimately benefitted their overall affect. For example, as Participant SS 
expressed, “The meditative part of it, you know, getting to that point of relaxation. It was 
very calming and very peaceful. I enjoyed it, I really did, yeah.” Participants also noted 
Body
• Feeling physical relaxation
• Having improved physical strength, endurance, and energy
• Experiencing optimized swallowing function
Breath
• Breathing deeper and easier
• Being in control of breaths
• Becoming aware of breaths
• Having quicker recovery from shortness of breath, without anxiety attached
• Experiencing improved shortness of breath, even during exertion
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• Feeling relaxed
o Having more energy
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• Having more positive emotions
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experiencing more positive emotions replacing negative ones throughout the day. As 
another participant stated, “I'm feeling better than I did because I was getting so 
frustrated with how this world is going right now…I noticed that I don't get ticked off as 
much as I am” (RT). Notably, this shift in affect led to changes in behaviors, such as 
decreased smoking and improved sleep, as three participants noted here: 
Often I smoke to combat a current, I don't know, stressor. That desire to go smoke 
seems to just go away, I- I don’t think I even realized that was happening until I 
realized, you know, how many pack of cigarettes, I still have left, for example, so 
it wasn't as conscious as one might think. (JL) 
 
I’ve always been a lousy sleeper. I fall asleep faster [now]. I mean and that's 
unheard of for me, usually takes me an hour to fall asleep so- so that's pretty 
good. I have not backed off on my sleeping medications at all…That's a huge 
jump. (JL) 
 
…lately I’ve just felt more peaceful where I'm not, you know, scatterbrained… 
and I quit taking the Zzzquil. I’ve only been taking the melatonin for about three 
days, and I've been sleeping just fine, usually I take both. (RF) 
 
Significantly, these changed behaviors in turn served to further improve mood, as 
expressed by Participant RF, “I'm in a better mood and happier, but I think because I'm 
sleeping better.” Similarly, participants expressed being more mindful overall, which also 
contributed to more general improvement in well-being. As one participant explained, 
“I'm just more mindful, you know it's like the- it's the catalyst to really, you know, try to 
take better care of myself” (PS). As a result of these positive changes, participants also 
noticed having more energy during the day and being able to accomplish more. 
I seem to get up and have a little bit more go than I used to… It used to be when I 
got up, you know, I feel drowsy and sleeping all day long. I still take a nap and 
stuff in the afternoon early afternoon for maybe 15 minutes or 20 minutes I'm not 
doing sleeping all the time, like I used to. (RT) 
 
And I'm not needing a nap in the afternoon, like I was before, I mean, there were 
many, many days a week where I would just feel worn out by 3:30 or four and 






I feel fairly relaxed and I seem to do a little bit more than I was. (RT) 
 
I've increased my jump rope, my weight lifting and all that. I up everything, and I 
think it's because I’m resting so much better at night that I have more energy. I've 
had more energy, so I felt like I can do more lately. (RF) 
 
As further contribution to the positive psycho-emotional impacts of the intervention, 
SKY also appeared to connect people socially and bring more positivity into the 
participants’ lives. 
I really enjoyed the breakout session that was, those were fun. That was kind of 
fun to meet somebody, you know. A complete stranger and to sit and talk, you 
know, even if it was for a few minutes and how quickly found common ground 
we found common ground. That was fun, I liked that. (SS) 
 
Making friends with [RF] that was kind of cool. We may actually stay in touch 
we- we exchanged email addresses. (PS) 
 
This is something to that I may be a little, I don't know, if you call it confident, 
but I always woke up in a morning wishing that I hadn't woke up, you know, I 
always wished, I was dead. And now it seems a little bit more than, you know, I 
would like to try a little harder at living because, you know, it's pretty final, the 
dead part once you're dead is. So I would like to, you know, I think [SKY] has 
changed my attitude, a little bit, you know, as far as looking at you know life that 
maybe- maybe I would like to hang around a while and see my grandkids grow up 
and so. (RK) 
 
 Secondly, the data revealed physiological benefits that participants experienced as 
a result of SKY, from increased body relaxation to enhanced physical strength and energy 
for various activities. 
I could feel my lower back relaxed, I could… I felt like I was getting better 
circulation down in my legs. (PS) 
 
And I actually do feel calmer, my shoulders are not up to my ears and sore as 
much as they were before, so I find value in it that way as well, not just 
emotionally but physically. (JL) 
More active. Doing more stuff. It kind of a pick-me-up. You know, it's kind of the 
vitamin. I don't know how but I noticed, I was doing more… I'm just doing more. 







I could walk a little longer than normal…even in the winter… I can at least walk a 
mile… [Previously], if I'm lucky, maybe half a mile…[now] takes a little longer 
but I can get it done. (WA) 
 
I have increased how I am the resistance on the bike so that I'm getting a better 
workout. That's happened within the past week, just feel like I can tolerate more. 
(SS) 
 
Of particular significance to the purpose of the current study, one participant summarized 
a clear benefit of these physiological changes on her swallowing physiology: 
When I get more stressed at silly things like right now the dog is being a pest but 
she's but I don't feel stressed about it that's just who she is see here’s your toy. But 
when I would feel stressed and then go for a drink of water, I know that I have to 
concentrate or I would choke on it, and now, in fact I just had a SIP of water, 
while we were talking I didn't even think about it, I just know I did because I saw 
the glass move. So it's I have to concentrate less, and I really think that the 
connection is the reduction of stress… Does everybody do it a different way, I 
really think that the tension that I carry I carry most of my tension in my neck, 
and my shoulders and so when I feel stressed, I think I constrict everything, and I 
think its physiological as well. (JL) 
 
The third theme that emerged surrounded breath. Participants shared that, “I’m 
not breathing as hard” (WA), which empowered them to be more active, “…knowing that 
I can control my breathing when I need to…not just huff and puff” (WA). The qualitative 
data revealed that SKY allowed participants to breathe deeper breaths in particular. As 
multiple participants indicated: 
When I take, I take a deep breath, I get it now. Before, it just seemed like I was, I 
get three quarters of a breath in. But I can really feel it in my lungs now… It 
makes me feel good. (RT) 
 
I felt like I noticed when I do my nebulizer treatment that I’m taking deeper 
breaths and it made me wonder if I have (it) expanded my lungs some from these 
exercises...when I take my nebulizer I can tell I'm taking deeper more meaningful 
breaths. (RF) 
 
Participants also shared that they become more cognizant about their breathing. 
 
I’m much more aware of the way I breathe and try to improve the transfer of 






I am finding myself- my awareness of my breathing in general is heightened… 
Definitely- definitely thinking more about and sort of evaluating my breathing. 
(JL) 
 
They also reported noticing that their shortness of breath had become less severe, even 
during exertion, and that when an episode of breathlessness did come on, they could 
recover from it more quickly, without the emotional consequences of anxiety attached.  
 
I found that I don't seem to be quite as short of breath when I climb a flight of 
stairs well, so I think it's just because I- I've noticed there's like, I've really noticed 
in the past, how it affects me it just doesn't seem to be as difficult… working on 
the deep breathing and just the relaxation of the deep breathing. I don't know. I’ve 
just noticed I haven't been in short of breath. (SS) 
 
I haven't noticed any difference in just my regular breathing, but I have noticed 
that when I feel short of breath, I seem to recover faster and part of that is being 
more mindful of my recovery breathing you know… it recovers it really well 
without that anxiety, you know. (PS) 
 
The walks that I take, and you know, I’m- I used to feel forced into them by the 
dog. But I think that our pace has increased. And my breathlessness upon walking 
uphill has reduced a little bit, I have noticed that. I'm not as out of breath when I 
go up all the hills that I go up... I noticed the lack of breathlessness after going on 
hills. (JL) 
 
One participant also commented that the frequency of their inhaler use had reduced since 
their participation in SKY. 
My breathing is fairly decent now. I haven't been using my inhalers as much… I 
was using them you know about every six hours and now I'm using them about 
two or three times a day. It's slowly went down a little bit. (RT) 
 
Overall, participants acknowledged that the impacts of COPD are accurately 
reflected through a mind-body-breath feedback loop (Lin & Shune, 2019) and that this 
loop occurs across all daily activities, “independent of eating” (RF). They also agreed 
that SKY, by improving aspects of the mind, body, and breath, was key in preventing or 
disrupting such cyclical psycho-physiological consequences.  
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Well yeah- yeah because it's, you know, I got some- some tools to- to use to 
combat the concern or frustration. (JK) 
 
Others shared that optimizing the quality of their breathing ultimately helped prevent 
further cyclical effects. 
Yeah the more you have trouble breathing and you get all those other things is 
anxiety and frustration and anger. That causes more shortness of breath so. It’s a 
vicious circle. (RK) 
 
I think [SKY] would help control your breathing...That way, you wouldn't have 
fear or panic once you control your breathing. (WA) 
 
Participants also described how SKY addresses the mind, body, and breath aspects of 
COPD simultaneously. 
I mean you're always concerned about your breathing but, you know, there's 
frustration and there's concern, and then it builds to anxiety and then it builds to 
fear and then it builds to panic and, if you can, if you can lower any of those that's 
going to be a benefit. (PS) 
 
I think [SKY will] address all of them [mind, body, breath]. (RT) 
 
The fear, anxiety, concern, panic, frustration causes an adrenaline rush, and then 
the adrenaline rush tends to lock up your throat. And then locking up your throat 
causes the coughing and shortness of breath and then that just further panics you 
which it's a- it feeds upon itself is what it does. I’m very familiar with this… The 
breathing exercises [from SKY] can help prevent these simple. (RF) 
 
Notably, participants had an overall positive experience with the SKY 
intervention. Participant JK felt “like I've accomplished something”. Three participants 
commented on how the SKY techniques were helpful as well as interesting and easy to 
learn. 
That was very interesting and helpful. (WA) 
 
You know it's not that strenuous of an exercise that it's gonna hurt you physically, 
you know, and which- which I like. (RK) 
 
It's been interesting. It's been I think it's helped me a lot… I've never done 
anything like this before and I think I've learned a lot from it, you know, from you 
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guys have been, I just didn't know what to expect and but it was, it's been fun. 
(RT) 
 
One participant shared that the depth of the program was worthwhile. 
My experience was positive, I learned a lot about breathing and the technique of 
breathing just breathing normally I became more aware of my breathing… I 
thought it was very comprehensive, as far as the three days. The overall program 
was comprehensive. (SS) 
 
Finally, all participants, regardless of disease severity, reported that based on their 
personal experiences with SKY, they would recommend such a program to their peers 
with COPD: 
For somebody that has [COPD], I guess, I would recommend [SKY]. It might 
possibly help them breathe deeper, become a little bit more relaxed. (GG) 
 
I know I’ve got a couple of friends that I’m already gonna tell about [SKY]. And 
I’m going to talk to my pulmonologist about trying to get a class going, I don't 
know, if we have any instructors nearby but obviously we can do it on Zoom. 
(PS) 
 
In particular, participants felt that they would recommend SKY because it was interesting 
and beneficial. 
Well yeah, I would recommend. Like I said, if you want some more people I’ll 
tell them over at the rehab thing but well, because it's interesting and I think it's 
helping- it's helping me. (JK) 
 
I think with COPD, the reason I did [SKY] is if I can do anything to help my 
breathing I'm going to do it. I think almost anybody in any physical condition can 
do it because it's all sitting and nothing really strenuous, which it doesn't, you 
know, I mean I don't hurt or get real sour, nothing, because of it. To me, it was 
worth it. You know, I mean it's helped me, I think. (RT) 
 
Overall, the participants also shared that SKY brought a new perspective of life, greatly 
contributing to its value. 
Hey I can't see any reason why anybody wouldn't want to, you know, after a 
while, improve the breathing or improve their attitude. I would recommend the 
program to them. (RK) 
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You know what was really good for me, was to see the variety of people that you 
had. Um, it wasn't, you know, things like this, have their own, I don't know, 
people have opinions about just a certain type of people that will do any sort of 
meditation or breathing exercises, etcetera, and, to me, the variety was. It made 
me feel good, made me feel like I could be a part of it and not feel like I had to 
pretend to be anybody or anything else. So that's- that's really good. I would 
recommend it because you know what COPD has a lot to do with personal stress 
and taking the time to reevaluate what sets you off and what doesn't set you off. 
And I think that's- that's an important discovery for me. (JL) 
 
Ten weeks after the completion of SKY, participants were given an opportunity to 
respond to a written open-ended question about whether there are any additional changes 
that they noticed since the interview that they think might have to do with SKY. 
Participant GG felt “happy to learn a new method of relaxation.” Participant JK shared 
that he recovers faster from shortness of breath and that “I think I’m breathing a little 
better.” Several participants commented that they continued to experience an improved 
state of mind as well as quality of life. 
“More attentive to self. More meditative and calm.” (JL) 
 
“I am more relaxed when I do the breathing...I enjoyed the training.” (SS) 
 
“I have learned to significantly relax more than in the past. There are things that 
seem to not bother me as much as they had before. I have found it easier to go to 
sleep after the exercises. I feel that my breathing is somewhat easier after 
exercising. I feel the training was well worth my time.” (RT) 
 
Perhaps even more broadly, one participant also expressed that he continues to feel 
hopeful about life and “a bit more interested in improving my health” (RK). 
Functional Relation Between SKY and Improved Consequences of COPD  
The second research question was aimed at exploring the functional relation 






intake experience). Specifically, this question asked whether there exists a functional 
relation between SKY and (a) dyspnea perceptions (i.e., work of breathing, WOB; 
shortness of breath, SOB; dyspnea-related distress, DD; and dyspnea-related anxiety, 
DA); (b) increased oral intake enjoyment; and (c) decreased oral intake difficulty. I 
hypothesized that the magnitude of perceived dyspnea would be reduced after the 
intervention (i.e., reduced dyspnea), and the mealtime enjoyment and difficulty will 
improve and reduce respectively. Below, I discuss the data visualizations, Tau-U and 
LRR statistical analyses. 
 Figure 4 graphically displays participants’ ratings of WOB on the Modified Borg 
Scale. At the individual level, a majority of the participants, except for Participants GG 
and JK, demonstrated variability in level (i.e., magnitude of the data) and trend (i.e., 
direction) across the baseline phase. There appeared to be a change in variability of rated 
WOB post-SKY for Participants WA, RK, and JL, with visual analysis revealing that 
these participants demonstrated a greater degree of stability post-SKY. When comparing 
the baseline data with the data gathered during the SKY and the post-intervention phases, 
Participant WA demonstrated a shift in level in the post-intervention phase, with the data 
indicating a stable level and trend. While he did demonstrate a single spike in the post-
intervention phase, he quickly returned to his post-intervention stability. Participant RT 
demonstrated a decreased trend towards the end of SKY with reduction in perceived 
WOB. For Participant SS, there was less drastic variability in perceived WOB during the 
post-intervention phase as compared to baseline. Overall, the influence of SKY on WOB 
differed across all of the participants, and each participant’s WOB rating differed across 







Figure 4. Perception of work of breathing severity.  
 
The results of the statistical analyses for WOB are summarized in Table 13 below. 
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effect size was calculated for Participant WA (.83) and Participant RT (.87). Participant 
JK had a Tau-U of zero; this was mirrored in the data visualization, where his perceptual 
ratings were consistently zero. Based on the LRR, six of the participants (i.e., WA, RK, 
RT, JL, SS, and PS) demonstrated varying degrees of improvement for perceived WOB 
(i.e., reduced WOB), ranging from 5.5% (SE = .13) to 61.28% (SE = .19); the other three 
participants (i.e., GG, JK, RF) showed no change. The greatest improvement was 
observed for Participant WA, followed by Participant RT. The treatment effect on WOB 
for Participant WA was estimated as -.95, 95% CI: [-1.33, -.57], corresponding to a 
decrease in WOB of 61.28%, 95% CI: [-73.52%, -43.38%]. Similar to the findings from 
the data visualization, a number of participants showed a high degree in variability across 
their ratings. In particular, Participants SS and RF had relatively high standard errors (SE 
= .35 and .38 respectively), corresponding to the variable level and trend observed on the 
data visualization.  
 
Table 13 
Work of Breathing Results 
Partici-
pant 















WA 0.83 -0.95 -61.28 0.19 [-1.33, -0.57] [-73.52, -43.38] 
RK 0.15 -0.13 -12.12 0.18 [-0.48, 0.23] [-38.39, 25.34] 
RT 0.87 -0.77 -53.55 0.15 [-1.06, -0.47] [-65.45, -37.56] 
JL 0.26 -0.06 -5.50 0.13 [-0.31, 0.20] [-26.6, 21.66] 
GG -0.11 NA NA NA NA NA 
SS -0.05 -0.06 -6.13 0.35 [-0.75, 0.63] [-52.93, 87.18] 
JK 0.00 NA NA NA NA NA 
PS 0.13 -0.08 -7.32 0.15 [-0.37, 0.22] [-30.83, 24.18] 
RF -0.15 0.07 7.04 0.38 [-0.68, 0.82] [-49.42, 126.51] 
Note. LRR-d is log response ratio – decrease. NA is not applicable or unable to calculate 
percentage changes. 
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 Figure 5 (below) graphically displays participants’ ratings of perceived SOB on the 
Modified Borg Scale. At the individual level, Participants WA, RT, JL, and SS demonstrated a 
more stable level post-intervention as compared to the other phases. Participants RT and SS 
demonstrated a change in level post-SKY, and Participants WA and JL exhibited more stability 
after SKY than before. Participant RK showed decreased variability in SOB ratings post-SKY 
as compared to before. Overall, the influence of SKY on SOB differed across all of the 
participants, and each participant’s SOB ratings differed across the study timepoints. 
 The results of the statistical analyses for SOB are summarized in Table 14 (below). 
In examining Tau-U, Participant RT demonstrated a medium-to-high effect (.82), while 
the effect size was small for the rest of the participants. Based on the LRR calculations, 
no improvements were observed for Participants GG and JK, which was reflected in their 
data visualizations, where their perceptions were mostly rated as zero. The remaining 
seven participants all demonstrated varying degrees of improvement, with percentage 
changes ranging from 2.9% (SE = .11) to 64.88% (SE = .51). Participants WA and RT 
exhibited the greatest degree of improvement in SOB. The effect of treatment estimated 
for Participant WA was -1.05, 95% CI: [-2.04, -.06], which corresponded to a decrease in 
SOB of 64.88%, 95% CI: [-86.96%, -5.41%]. Participants WA and SS had the largest 
standard error, at .51 and .42 respectively, likely representative of the variable level and 
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Shortness of Breath Results 
Partici- 
pant 















WA 0.49 -1.05 -64.88 0.51 [-2.04, -0.06] [-86.96, -5.41] 
RK 0.32 -0.30 -25.66 0.23 [-0.75, 0.15] [-52.56, 16.49] 
RT 0.82 -0.56 -42.96 0.09 [0.73, -0.39] [-51.97, -32.26] 
JL 0.17 -0.03 -2.90 0.11 [-0.24, 0.18] [-21.48, 20.07] 
GG -0.11 NA NA NA NA NA 
SS -0.28 0.35 41.66 0.42 [-0.47, 1.17] [-37.69, 222.05] 
JK 0.00 NA NA NA NA NA 
PS 0.03 -0.08 -7.37 0.17 [-0.40, 0.25] [-33.23, 28.5] 
RF -0.11 -0.22 -19.48 0.37 [-0.95, 0.52] [-61.35, 67.67] 




 Figure 6 graphically displays participants’ ratings of DD on the Modified Borg 
Scale. Comparing the baseline phase with the intervention phase, Participant WA 
demonstrated a more stable level and trend post-SKY. Participant RT exhibited stable 
level post-SKY. Participant JL demonstrated greater stability post-SKY, and Participant 
SS presented a change in level post-SKY. Finally, Participant RF presented with 
consecutive days of stable level and trend a few days before the start of intervention 
towards the end of the data collection period. Overall, the influence of SKY on DD 
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As displayed in Table 15, participants’ responses varied based on effect size 
calculations. Participant RT showed the greatest treatment effect (.83; medium-to-high) 
while a majority of the other participants demonstrated a small effect. Participant JK had 
a Tau-U of zero; this was mirrored in the data visualization, where his perceptual ratings 
were consistently zero. Based on the LRR calculations, no improvements were observed 
for Participants GG and JK, likely reflecting the majority of their ratings being zero as 
observed in the data visualization. The remaining six participants all demonstrated 
varying degrees of improvement, with percentage changes ranging from 21.25% (SE = 
.21) to 61.99% (SE = 1.07). Of those six, the greatest improvement was observed for 
Participant RF, with the effect of treatment estimated as -.97, 95% CI: [-3.06, 1.13], 
which corresponded to a decrease in DD of 61.99%, 95% CI: [-95.32%, 208.96%]. 
Participant RF also demonstrated the largest standard error at 1.07, likely reflecting his 
variable level and trend in the baseline phase as well as a spike in severity rating 
observed on the last day of data collection post SKY.  
 Figure 7 graphically displays participants’ ratings of DA on the Modified Borg 
Scale. Most noticeably, participants WA, RK, RT, and JL demonstrated multiple days of 
stable level and trend post-SKY, without a clear change in variability, when compared to 












Dyspnea-Related Distress Results  
Partici-
pant 















WA 0.33 -0.50 -39.27 0.58 [-1.63, 0.63] [-80.37, 87.82] 
RK 0.43 -0.26 -23.02 0.12 [-0.50, -0.02] [-39.27, -2.41]  
RT 0.83 -0.73 -52.00 0.16 [-1.05, -0.42] [-64.93, -34.29] 
JL 0.36 -0.25 -22.11 0.18 [-0.60, 0.10] [-44.85, 10.01]  
GG -0.11 NA NA NA NA NA 
SS -0.03 -0.35 -29.18 0.64 [-1.60, 0.91] [-79.77, 147.86]  
JK 0.00 NA NA NA NA NA 
PS 0.33 -0.24 -21.25 0.21 [-0.65, 0.17] [-47.67, 18.51]  
RF 0.15 -0.97 -61.99 1.07 [-3.06, 1.13] [-95.32, 208.96]  
Note. LRR-d is log response ratio – decrease. NA is not applicable or unable to calculate 
percentage change.
 
  Statistics for DA are displayed in Table 16. Based on the Tau-U calculations, six 
participants (WA, RK, RT, JL, PS, and RF) demonstrated a small effect size, and the 
remaining three (GG, SS, and JK) demonstrated no effect. For example, Participant JK 
had a Tau-U of zero, which was mirrored in the data visualization, where his perceptual 
ratings were consistently zero. With regard to LRR calculations, no improvements were 
observed for Participants GG, SS, and JK, which was consistent with their data 
visualizations, where perceptual responses hovered around zero. The remaining six 
participants all demonstrated varying degrees of improvement, with percentage changes 
ranging from 15.52% (SE = .12) to 68.15% (SE = .45). Participant WA exhibited the 
greatest improvements. His estimated LRR for DA was -1.09, 95% CI: [-2.26, .08], 
corresponding to a decrease in DA of 66.35%, 95% CI: [-89.53%, 7.96%]. RT had a 
standard error of .45, which was likely a result of his variable level and trend on the data 
visualization. 
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Dyspnea-Related Anxiety Results  
Partici-
pant 















WA 0.54 -1.09 -66.35 0.60 [-2.26, 0.08] [-89.53, 7.96] 
RK 0.31 -0.17 -15.52 0.12 [-0.40, 0.06] [-32.78, 6.18] 
RT 0.55 -1.14 -68.15 0.45 [-2.03, -0.26] [-86.8, -23.14] 
JL 0.38 -0.25 -22.11 0.18 [-0.60, 0.10] [-44.85, 10.01] 
GG -0.11 NA NA NA NA NA 
SS -0.23 0.82 127.18 1.07 [-1.27, 2.91] [-71.86, 1734.33] 
JK 0.00 NA NA NA NA NA 
PS 0.58 -0.50 -39.06 0.25 [-0.09, 0.00] [-62.92, .15] 
RF 0.14 -0.38 -31.47 1.11 [-2.54, 1.79] [-92.14, 497.82] 




 With regard to the mealtime experience questions, a functional relation was 
questionable between perceived mealtime enjoyment and SKY, as displayed in Figure 8. 
No individual patterns were observed. 
 Table 17 summarizes the statistics for mealtime enjoyment. The Tau-U effects 
were small to none for all participants. The LRR calculations suggested five participants 
(RK, RT, JL, GG, and SS) demonstrated varying degrees of change, ranging from 4.20% 
(SE = .08) to 31.09% (SE = .08). The greatest potential improvement was observed for 
Participant JL, where the effect of treatment was estimated as .27, 95% CI: [.11, .43], 
corresponding to an increase in enjoyment of 31.09%, 95% CI: [12.1%, 53.29%]. This 
improvement was likely accounted for by dental issues she was experiencing during the 
first few days of the baseline data collection phase and is consistent with data 
visualization, in which she demonstrated an initial decrease in ratings, indicating little to 
no mealtime enjoyment, and later rise, suggesting more mealtime enjoyment. 
 



















   
  
   
   
  
   




   
   
  
   
   
   
  
   
   
  







   
  
   
   
  
   
   
  
   
   
  
   
   
  
   
   
   
  
   































1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
PS
RF
Baseline                 SKY                              Post Intervention
Session
 




Mealtime Enjoyment Results  
Partici-
pant 















WA -0.17 -0.08 -7.56 0.10 [-0.28, 0.12] [-24.21, 12.75] 
RK 0.09 0.05 5.12 0.22 [-0.38, 0.48] [-31.78, 61.98] 
RT 0.34 0.09 9.93 0.06 [-0.02, 0.21] [-1.98, 23.29] 
JL 0.60 0.27 31.09 0.08 [0.11, 0.43] [12.10, 53.29] 
GG 0.01 0.04 4.20 0.08 [-0.12. 0.20] [-11.10, 22.13] 
SS 0.46 0.13 13.83 0.05 [0.03, 0.23] [3.33, 25.39] 
JK -0.20 -0.09 -8.43 0.07 [-0.23, 0.05] [-20.20, 5.09] 
PS 0.30 0.00 -0.10 0.15 [-0.30, 0.29] [-25.57, 34.08] 
RF -0.05 -0.01 -0.71 0.07 [-0.15, 0.14] [-13.90, 14.49] 
Note. LRR-i is log response ratio – increase.  
 
With regard to mealtime difficulty, a functional relation was questionable 
between difficulty and SKY, as displayed in Figure 9. 
Table 18 summarizes the statistics for mealtime difficulty. Small effects were 
observed for most participants. Participant JK had a Tau-U of zero, which was mirrored 
in the data visualization, where his perceptual ratings were consistently zero. Based on 
the LRR calculations, three participants (WA, RK, and RT) demonstrated varying 
degrees of change, ranging from 48.53% (SE = .39) to 82.19% (SE = 1.24). Data for 
Participants WA and RT indicated the greatest magnitude of reductions in difficulty. 
Participant WA achieved an effect of treatment estimated as -1.73, 95% CI: [-4.15, .7], 
which corresponded to a decrease in difficulty of 82.19%, 95% CI: [-98.43%, 101.47%]. 
His amount of percentage change was likely a result of a change in variability when 
comparing baseline and SKY phases with post intervention. Participant RT exhibited an  
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effect of treatment estimated as -1.07, 95% CI: [-2.21, .07], corresponding to a reduction 
in difficulty of 65.81%, 95% CI: [-89.08, 70]. 
 
Table 18 
Mealtime Difficulty Results  
Partici-
pant 















WA 0.25 -1.73 -82.19 1.24 [-4.15, 0.70] [-98.43, 101.47] 
RK 0.43 -0.66 -48.53 0.39 [-1.42, 0.09] [-75.91, 9.94] 
RT 0.40 -1.07 -65.81 0.58 [-2.21, 0.07] [-89.08, 70] 
JL 0.35 NA NA NA NA NA 
GG -0.11 NA NA NA NA NA 
SS 0.02 0.17 18.55 1.24 [-2.25, 2.59] [-89.50, 1238.38] 
JK 0.00 NA NA NA NA NA 
PS 0.02 0.13 13.38 0.22 [-0.30, 0.55] [-25.92, 73.54] 
RF 0.13 NA NA NA NA NA 




 Participants were also asked to fill out surveys at three different study timepoints: 
Time 0 (before SKY), Time 2 (1-25 days post SKY), and Time 3 (10 weeks post SKY). 
Using the Hospital Anxiety and Depression Scale (HADS), Positive and Negative Affect 
Schedule (PANAS), COPD Assessment Test (CAT), Eating Assessment Tool (EAT-10), 
and Dysphagia Handicap Index (DHI), we explored potential changes in psychological 
status, COPD impact on life, and swallowing-related functioning. The survey results 
before and after the intervention for each participant are available in Table 19, and a 
summary of the descriptive statistics across all participants is in Table 20. 
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 Below I discuss the results of the observed changes across these surveys, drawing 
on the clinical interpretation of scores as supported by the previous literature. For each 
survey, changes in Times 0 (baseline), Time 2 (immediately post SKY), and Time 3 (10-
weeks post SKY) are presented.  
HADS 
 At Time 0, one participant (WA) had a score indicative of the presence of 
depression (“case”). When comparing Time 0 to Time 2, WA demonstrated 
improvement, with his score at Time 2 indicating within the normal range. Two 
participants continued to have scores in the same category of severity across these two 
timepoints: one was suggestive of the presence of a suspected case (RK) and the other 
borderline risk of depression (PS). However, Participant PS also had a change of >1.5 
points from baseline, which is the suggested threshold for determining a minimal 
important difference among individuals with COPD (Puhan et al., 2008). The remaining 
six participants scored within the normal range at Times 0 and 2. By Time 3, eight 
participants (all but RK) scored within the normal range; Participant RK’s score remained 
suggestive of the presence of a suspected case.  
 With regard to the degree of anxiety, three participants (RK, JL, PS) had scores 
indicative of the presence of anxiety (“case”) at baseline. When comparing Time 0 to 
Time 2, all three demonstrated improvement, with scores indicating within the normal 
range (RK and JL) or risk of anxiety (“borderline base”; PS). At Time 0, one participant 
(RT) had a score suggestive of borderline risk of anxiety. When comparing Time 0 to 
Time 2, his scores demonstrated improvement, indicating within the normal range by 
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Time 2. The remaining five participants scored within the normal range at Times 0 and 2. 
At Time 3, all nine participants’ scores fell within the normal range.  
 Overall, across the three timepoints, there was a trend for decreased mean scores 
across all participants for both depression (M = 6.44, SD = 4.07; M = 4.67, SD = 4.58; M 
= 4.00, SD = 4.03, for Time 0, 2, and 3, respectively) and anxiety (M = 6.33, SD = 3.31; 
M = 5.56, SD = 2.13; M = 4.56, SD = 1.51, for Time 0, 2, and 3, respectively).  
PANAS 
 In terms of the changes in positive and negative affect for Times 0 and 2, eight 
participants (WA, RK, RT, JL, SS, JK, PS, RF) demonstrated an upward shift in positive 
emotions, with change in scores ranging from 1 to 17 (see Table 19). GG demonstrated a 
decrease of positive affect by 14. At Time 3, the same eight participants (WA, RK, RT, 
JL, SS, JK, PS, RF) exhibited improved positive affect as compared to Time 0, with 
change in scores ranging from 3 to 13 points. Participant GG again showed a decrease of 
positive affect, with a change in score of 4 from Time 0 to Time 3. For negative affect, 
five participants (RT, JL, SS, PS, RF) showed decreased negative affect, with change in 
scores ranging from 4 to 13 points. Three participants had the same scores at Time 0 and 
Time 2 (WA, GG, and JK). RK demonstrated an increase in negative affect score by 4. At 
Time 3, eight participants (WA, RK, RT, JL, SS, JK, PS, RF) exhibited lowered negative 
affect as compared to Time 0, with change in scores ranging from 1 to 17 points. 
Participant GG had the same score at both Time 0 and Time 3. 
 Overall, across the three timepoints, there was increased positive affect (M = 4.78, 
SD = 8.77; M = 29.33, SD = 8.40; M = 30.22, SD = 8.56, for Time 0, 2, and 3, 
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respectively) and decreased negative affect (M = 17.89, SD = 7.07; M = 14.67, SD = 
7350; M = 12.89, SD = 4.65, for Time 0, 2, and 3, respectively) across the participants.  
CAT 
 At Time 0, three participants (WA, JL, PS) demonstrated scores indicative of high 
symptomatic impact of COPD. When comparing Time 0 to Time 2, two of these 
participants demonstrated scores suggestive of improvements, with scores at Time 2 
indicating a medium impact for Participants WA and PS. Scores for JL remained in the 
same category of impact (i.e., high), although there was a drop of score by three points. 
Four participants (RK, RT, SS, JK, RF) demonstrated scores indicative of medium 
symptomatic impact of COPD at Time 0. When comparing those to Time 2, two 
participants (SS, RF) demonstrated scores suggestive of improvements, with scores 
indicating low impact for both. Two participants (RT, JK) remained in the same level of 
impact (i.e., medium) at Time 2, with a decrease of five points and an increase of one 
point, respectively. Further, when comparing Time 0 with Time 2, Participant GG shifted 
from normal to low impact. At Time 3, one participant (JL) had score that reflected high 
COPD symptomatic impact (same rating as Time 0 and Time 2); six participants (WA, 
RK, RT, JK, PS, RF) had scores indicating medium impact; one participant (SS) had a 
score indicating low impact; and one participant (GG) scored in the normal range. 
 Examining the mean scores across all participants, there was a reduction of COPD 
symptomatic impacts and decreased standard deviation from Time 0 to Time 2 that was 
maintained at Time 3 (M = 17.89, SD = 8.07; M = 14.56, SD = 6.29; M = 14.78, SD = 
6.20, for Time 0, 2, and 3, respectively), although all of these mean scores are classified 
in the medium impact range. 
 




 At Time 0, six participants (WA, RK, RT, JL, GG, PS) had scores ≥ 3, which is 
indicative of the presence of dysphagia (Belafsky et al., 2008). Comparing Time 0 to 
Time 2, four of the participants (WA, RK, RT, GG) presented with the same profile; 
however, at Time 2, the scores for Participants JL and PS did not suggest the presence of 
dysphagia. The remaining three participants’ scores (SS, JK, RF) did not suggest 
presence of dysphagia at Time 0 or Time 2. Additionally, at both Times 0 and 2, 
Participant RK’s scores were indicative of risk of aspiration (Regan et al., 2017). 
Participant WA similarly had a score suggestive of risk of aspiration at Time 0, but not at 
Time 2. At Time 3, one participant (RK) remained to be at risk for aspiration, and three 
participants (WA, RK, JL) had scores that still suggested presence of dysphagia. 
 Across all participants, group means suggested a slight reduction in self-reported 
swallowing difficulties from Time 0 to Time 2 that were maintained at Time 3 (M = 4.33, 






When looking at the combined physical, functional, and emotional scores, five 
participants (RT, JL, SS, PS, RF) demonstrated a reduction in scores from Time 0 to 
Time 2, ranging from 2 to 6 points. Two participants (WA, GG) scored the same. Two 
participants (RK, JK) demonstrated an increase in scores from Time 0 to Time 2, ranging 
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from 6 to 14 points. At Time 3, seven participants (WA, RT, JL, GG, SS, PS, RF) 
demonstrated a reduction in total points as compared to Time 0, ranging from 2 to 12 
points. Two participants (RK, JK) exhibited an increase in total points from Time 0 to 
Time 3, ranging from 1 to 2 points. For the self-perceived difficulty, at Time 0, four 
participants (WA, JL, JK, RF) rated difficulty as normal and five (RK, RT, GG, SS, PS) 
rated difficulty as mild. At Time 2, five participants (GG, SS, JK, PS, RF) rated difficulty 
as normal and four (WA, RK, RT, JL) rated difficulty as mild. At Time 3, the same five 
participants (GG, SS, JK, PS, RF) rated difficulty as normal and the remaining four (WA, 
RK, RT, JL) rated difficulty as mild. 
Across all participants, group means suggested a slight reduction in the physical 
impact of swallowing score across all three timepoints (M = 8.6, SD = 4.01; M = 8.44, 
SD = 4.56; M = 7.11, SD = 4.62, for Time 0, 2, and 3, respectively). The overall 
functional impact of swallowing score indicated a reduction from Time 0 to 3 (M = 2.22, 
SD = 2.73; M = 1.56, SD = 3.28, for Time 0 and 3, respectively). The group means 
suggested a slight reduction in the emotional impact of swallowing score across time (M 
= 2.22, SD = 2.73; M = 1.78, SD = 2.73; M = 1.56, SD = 1.94, for Time 0, 2, and 3 
respectively). The overall self-perceived swallowing difficulty showed a slight increase 
from Time 0 to Time 3 (M = 1.56, SD = .73; M = 1.56, SD = .73; M = 1.67, SD = .87, for 







Survey Scores for Each Participant at Times 0, 2, and 3 (T0 / T2 / T3) 
Participant HADS  PANAS  CAT  EAT-10  DHI  
WA Depression 12 / 3 / 2 
Anxiety 2 / 4 / 3 
Positive 13 / 23 / 20 
Negative 11 / 11 / 10 
30 / 16 / 15 9 / 4 / 7 Regular food and liquid (T0, T2) 
Soft food, meats cut small and 
regular liquid (T3) 
Physical 10 / 12 / 8 
Functional 2 / 2 / 0 
Emotional 2 / 0 / 2 
Swallowing difficulty 1 / 3 / 3 
RK Depression 12 / 15 / 13 
Anxiety 8 / 7 / 7 
Positive 13 / 17 / 16 
Negative 30 / 34 / 24 
20 / 21 / 18 9 / 14 / 15 Regular food and liquid 
Physical 12 / 16 / 16 
Functional 2 / 8 / 2 
Emotional 4 / 8 / 2 
Swallowing difficulty 2 / 2 / 2 
RT Depression 5 / 3 / 4 
Anxiety 8 / 7 / 5 
Positive 25 / 34 / 38 
Negative 16 / 12 / 11 
18 / 13 / 14 8 / 3 / 2 Regular food and liquid 
Physical 12 / 12 / 12 
Functional 4 / 2 / 2 
Emotional 2 / 2 / 2 
Swallowing difficulty 3 / 2 / 3 
JL Depression 7 / 4 / 7 
Anxiety 11 / 4 / 6 
Positive 21 / 38 / 28 
Negative 17 / 12 / 16 
25 / 22 / 27 4 / 1 / 3 Moist-easy-to-chew food with 
regular liquid (T0, T2) 
Soft foods, meats cut small and 
regular liquid (T3) 
Physical 10 / 8 / 8 
Functional 8 / 12 / 10 
Emotional 8 / 4 / 6 







Table 19 (continued). 
Participant HADS  PANAS  CAT  EAT-10  DHI  
GG Depression 1 / 0 / 0 
Anxiety 5 /5 / 5 
Positive 34 / 20 / 30 
Negative 10 / 10 / 10 
3 / 8 / 5 4 / 3 / 1 Regular food and liquid 
Physical 6 / 4 / 1 
Functional 0 / 2 / 0 
Emotional 0 / 0 / 0 
Swallowing difficulty 2 / 1 / 1 
SS Depression 3 / 2 / 0 
Anxiety 3 / 2 / 2 
Positive 36 / 37 / 40 
Negative 17 / 13 / 9 
10 / 6 / 8 0 / 0 / 0 Regular food and liquid 
Physical 2 / 2 / 4 
Functional 0 / 0 / 0 
Emotional 0 / 0 / 0 
Swallowing difficulty 1 / 1 / 1  
JK Depression 5 / 6 / 4 
Anxiety 4 / 7 / 4 
Positive 22 / 24 / 26 
Negative 14 / 14 / 13 
17 / 18 / 14 0 / 1 / 0 Regular food and liquid 
Physical 2 / 8 / 3 
Functional 0 / 0 / 0 
Emotional 0 / 0 / 0 
Swallowing difficulty 1 / 1 / 1 
PS Depression 10 / 8 / 4 
Anxiety 11 / 9 / 4 
Positive 24 / 32 / 35 
Negative 29 / 16 / 12 
23 / 20 / 17 4 / 1 / 2 Regular food and liquid 
Physical 12 / 10 / 6 
Functional 4 / 2 / 0 
Emotional 4 / 2 / 2 
Swallowing difficulty 2 / 1 / 1 
RF Depression 3 / 1 / 2 
Anxiety 5 / 5 / 5 
Positive 35 / 39 / 39 
Negative 17 / 10 / 11 
15 / 7 / 15 1 / 1 / 1 Regular food and liquid 
Physical 8 / 4 / 6 
Functional 0 / 0 / 0 
Emotional 0 / 0 / 0  
Swallowing difficulty 1 / 1 / 1 
Note. CAT = COPD Assessment Test. DHI = Dysphagia Handicap Index. HADS = Hospital Anxiety and Depression Scale.  
PANAS = Positive and Negative Affect Schedule. T0, T2, and T3 are Time 0, before SKY; 2, immediately after SKY;  







Descriptive Statistics Across All Participants at Times 0, 2, and 3 (T0 / T2 / T3) 
Participant HADS  PANAS  CAT  EAT-10  DHI  
Mean Depression  
6.44 / 4.67 / 4.00 
Anxiety  
6.33 / 5.56 / 4.56 
Positive  
4.78 / 29.33 / 30.22 
Negative  







Physical 8.60 / 8.44 / 7.11 
Functional 2.22 / 3.11 / 1.56 
Emotional 2.22 / 1.78 / 1.56 
Swallowing difficulty 1.56 / 1.56 / 1.67 
Max Depression  
12 / 15 / 13 
Anxiety  
11 / 9 / 7 
Positive  
36 / 38 / 40 
Negative  





14 /  
15 
Physical 12 / 16 / 16 
Functional 8 / 12 / 10 
Emotional 8 / 8 / 6 
Swallowing difficulty 3 / 3 / 3 
Min Depression  
1 / 0 / 0 
Anxiety 
 2 / 2 / 2 
Positive  
13 / 17 / 16 
Negative  







Physical 0 / 2 / 1 
Functional 4 / 0 / 0 
Emotional 0 / 0 / 0 
Swallowing difficulty 1 / 1 / 1 
SD Depression  
4.07 / 4.58 / 4.03 
Anxiety  
3.31 / 2.13 / 1.51 
Positive  
8.77 / 8.40 / 8.56 
Negative  







Physical 4.01 / 4.56 / 4.62 
Functional 2.73 / 4.14 / 3.28 
Emotional 2.73 / 2.73 / 1.94 
Swallowing difficulty .73 / .73 / .87 
Note. CAT = COPD Assessment Test. DHI = Dysphagia Handicap Index. HADS = Hospital Anxiety and Depression Scale.  
PANAS = Positive and Negative Affect Schedule. T0, T2, and T3 are Time 0, before SKY; 2, immediately after SKY;  








The purpose of this study was to explore the viability of SKY, a breathing-based 
meditation program, for improving dyspnea and the mealtime experience among 
individuals with COPD. A growing body of research supports the impact of COPD and 
dysphagia on both the physiological and the psycho-emotional aspects of life. However, 
effective evidence- and fidelity-based treatments that target both the physiological and 
the psycho-emotional nature of these diseases remain underexplored. Interventions 
grounded in promoting a positive mind-body-breath feedback loop, such as SKY, may 
effectively address this need. Therefore, using a mixed-method design, this study 
investigated the feasibility and acceptability of SKY among individuals with COPD as 
well as the functional relation between SKY and (a) perceived dyspnea and (b) mealtime 
enjoyment and difficulty. This study represents the first systematic examination of the 
potential for SKY to be used as an intervention for individuals with COPD, including the 
role it plays in influencing the psycho-physiological aspects of life in this population. I 
hypothesized that following SKY, perceived work of breathing (WOB), shortness of 
breath (SOB), dyspnea-related distress (DD), and dyspnea-related anxiety (DA) would 
improve, mealtime enjoyment would increase, and mealtime difficulty would decrease.  
This chapter first discusses the findings from both the qualitative (Research 
Question 1) and the single-case (Research Question 2) components of the current study 
with mention of the descriptive statistics where appropriate. Then, the limitations, future 
directions, and overall conclusions will be presented.  
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Acceptability and Feasibility of SKY Among Individuals with COPD 
 Our qualitative data and fidelity outcomes support SKY to be an acceptable and 
feasible program for individuals with COPD. Overall, the participants found the program 
to be enjoyable, helpful, and easy to follow, and their positive experience with the 
program was reflected in the high attendance rate and their willingness to share SKY with 
other individuals with COPD.  
 Firstly, all participants were able to engage in the intervention successfully. Five 
days before the start of SKY, participants learned a component of the technique (i.e., 
victorious breath). The purpose of this initial training was to help participants get 
acclimated to the controlled and trained breathing technique, particularly given concerns 
that the breathing techniques may be more challenging for individuals with COPD. 
However, as reflected in the intervention fidelity data, all of the participants were able to 
perform all of the SKY components accurately; excellent inter-rater reliability was 
achieved to support intervention fidelity. Further, no adverse effects of SKY were 
reported. The qualitative data further supported participants’ engagement and the 
feasibility of the techniques. A couple of participants shared, after learning the victorious 
breath, that “Finished one just a little while ago. It does seem to help my breathing some. 
Looking forward to doing more” (RT), and “It definitely helps to practice” (SS).   
 Secondly, our data reveal that intervention adherence was 90% (1/10 drop-out 
rate), with all nine of those participants completing SKY in its entirety. Further, most of 
the participants (66.67%; 6/9) were even able to continue their daily SKY home practice 
regularly at least four times a week; the remaining three had a practice frequency of 1-3 
days a week. These numbers likely suggest that SKY was acceptable to the participants 
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and that they were willing to commit their time to the SKY schedule and practice. 
Notably, these rates are in stark contrast with the adherence rates previously reported for 
more standard COPD-related treatments. The Global Initiative on Obstructive Lung 
Disease recommends that patients with COPD, whose FEV1 falls below normal, should 
be referred for pulmonary rehabilitation. Pulmonary rehabilitation has been reported as an 
important non-pharmacological treatment for COPD, with its benefits ranging from 
improved exercise tolerance and quality of life to reduced perceived fatigue and dyspnea 
(Nici et al., 2006; Ries et al., 2007). However, treatment drop-out is often a concern. One 
study reported a 23% drop-out rate with pulmonary rehabilitation (Fischer et al., 2009). 
Other studies report the noncompletion rates of pulmonary rehabilitation can be over 
70%, although usually they are reported to be between 20% and 40% (Fischer et al., 
2009). Various factors can influence treatment adherence. It has been postulated that 
among the COPD comorbidities, anxiety and depression plays a major role in adherence 
(Qian et al., 2014; Yohannes et al., 2010). An individual’s “common sense” towards 
whether a certain treatment is considered a sensible thing to do can also play a role 
(Kaptein et al., 2009). As explained by Leventhal’s Common Sense Model, the 
individual’s schemata towards the underlying illness, or their perception of the illness, 
guides the person’s actions in coping with health threat, which would contribute to 
adherence (or nonadherence) (Leventhal et al., 1992). It has also been reported that an 
individual’s perceived health status is most influential in the completion of rehabilitation 
(Selzler et al., 2012). Finally, fear of dyspnea and exercise can also be related to 
rehabilitation program adherence (Harrison et al., 2015). The high adherence rate (i.e., 
low drop-out) achieved in this current study was likely related, in part, to its lack of 
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needed exertion or other physical activities. In the interviews, participants specifically 
stated that anyone in any physical condition can participate because SKY is “all sitting 
and nothing really strenuous” (RT). Not surprisingly given the variable drop-out rates, 
30% of patients who participate in pulmonary rehabilitation do not demonstrate improved 
health status or exercise tolerance (Garrod et al., 2004). On the contrary, all of our 
participants reported at least some gains related to mind-body-breath. 
 Thirdly, as related to the burden of disease, our findings also suggest that SKY is 
a feasible intervention for benefiting multiple aspects of life in individuals with COPD, 
encompassing the mind, body and breath, regardless of disease severity. Participants 
reported the SKY experience as “interesting” and “helpful.” They enjoyed SKY because 
it was “not that strenuous of an exercise that it's gonna hurt you physically” (RK). They 
also shared mind-body-breath benefits after SKY as evidenced by improved COPD-
related burden: feeling relaxed, sleeping better, having more energy, breathing deeper and 
easier, being in control of breaths, and having quicker recovery from shortness of breath 
without anxiety attached.  
 These psycho-physiological results are consistent with the previous SKY research 
in which widespread benefits were observed across multiple populations. For example, 
most recently, an online SKY program delivered to 92 healthcare professional during 
COVID-19 demonstrated a significant reduction in stress, anxiety, and depression 
immediately after the program, as well as significant improvement in life satisfaction, 
resilience, and quality of sleep (Divya et al., 2021). Prior to the pandemic, research on in-
person interventions indicated that SKY can help restore and enhance mental health, by 
relieving anxiety and depression (Katzman et al., 2012, Kjellgren et al., 2007; Seppälä et 
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al., 2014, Vedamurthachar et al., 2006), reduce addictive behaviors (Kochupillai et al., 
2005), improve emotional regulation (e.g., Descilo et al., 2010, Goldstein et al., 2016, 
Newman et al., 2020, Sureka et al., 2014, Katzman et al., 2012, Kharya  et al., 2014), 
increase self-esteem, optimism, joviality, life satisfaction, and quality of life (Descilo et 
al., 2010; Jyotsna et al., 2012; Kjellgren et al., 2007; Sureka et al., 2014; Warner & Hall, 
2012), improve social connectedness (Seppälä et al., 2020), and enhance sleep quality 
(Sulekha et al., 2006). Previous SKY research has also supported enhancements at the 
biochemical level, including a reduction of stress markers (e.g., cortisol, corticotrophin, 
blood lactate) (Carter et al., 2013, Kumar et al., 2013; Mulla & Vedamuthachar, 2014, 
Sharma et al, 2003, Vedamurthachar et al., 2006) as well as an increase in biomarkers 
associated with well-being (Shetty et al., 2006). Further, improved respiratory function 
(e.g., reduced respiratory rate and increased lung capacity) has also been associated with 
SKY (Bodi et al., 2008; Chavhan et al., 2013, Kale et al., 2016; Seppälä et al., 2014, 
Somwanshi et al., 2013). Based on our qualitative data, it is clear that individuals with 
COPD perceive similar benefits of SKY as compared to individuals with other health 
conditions as well as healthy individuals, who have been targeted in the previous 
literature. 
A recent meta-synthesis of the qualitative research, aimed at systematically 
understanding the lived experience of COPD, revealed a number of themes that described 
the experience and the ongoing needs of individuals with COPD (Disler et al., 2014). 
These themes included: (a) understanding of the condition (individuals wanting better 
understanding of condition); (b) sustained symptom burden (breathlessness, fatigue, and 
frailty); and (c) the unrelenting psychological impact of living with COPD (anxiety, 
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social isolation, loss of hope, and maintaining meaning). Relatedly, the management of 
the symptoms and concerns for individuals with COPD often encompass treatment for 
breathlessness, fatigue, anorexia, pain, depression, anxiety, cough, and daytime 
sleepiness and insomnia (Farquhar et al., 2016; Higginson et al., 2014; Maddocks et al., 
2017). Significantly, these reported lived experiences as well as management symptoms 
and concerns map onto the qualitative themes that emerged in the current study, 
particularly in terms of aspects of daily life that were positively influenced by SKY. 
Based on the changes that our participants shared after their participation in SKY, it is 
evident that the program can serve individuals with COPD multi-dimensionally and, 
when taken together with the previous literature, suggests that SKY can target multiple 
important domains of disease burden in COPD.  
 The sequelae of COPD often influence one another via feedback and feedforward 
loops (Lin & Shune, 2019, 2020). For example, the consequences of anxiety and 
depression in individuals with COPD are associated with increased functional disability 
and healthcare utilization as well as decreased quality of life and survival. Health-related 
quality of life in individuals with COPD is further complicated and adversely affected by 
frequent exacerbations, which further increase anxiety and depression (e.g., Yohannes et 
al., 2010; Yohannes et al., 2016). The secondary sequalae, such as increased economic 
burden and decreased quality of life, are a likely result of this combination of the primary 
physiological and psycho-emotional impacts of COPD (Bentsen et al., 2014; Hynninen et 
al., 2005; Miravitlles, 2004; Yohannes et al., 2010). COPD exacerbations are also linked 
to dysphagia in a cyclical manner (Steidl et al., 2014): when an individual’s swallow 
response is impaired, they are at increased risk for exacerbation; and when an individual 
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undergoes acute exacerbation, they are more likely to exhibit an impaired swallow reflex 
(Kobayashi et al., 2007; Terada et al., 2010).  
 Similar cyclical relations between disease sequelae have also been reported in 
individuals with COPD without a diagnosis of dysphagia during oral intake (Lin & 
Shune, 2019). In that study, participants acknowledged the ways that their bodies 
physiologically responded during oral intake (i.e., dyspnea, coughs), but also how they 
then responded emotionally to those physiological sensations (e.g., fear, anxiety, panic). 
Consequently, the physiological-rooted emotions triggered more physiological responses, 
thereby further disrupting the oral intake experience and oral intake enjoyment. Given the 
substantial impact COPD has on eating and drinking, in light of the feedback and 
feedforward influences on oral intake, it is essential to investigate comprehensive 
treatment programs that account for both the physiologic and psycho-emotional 
components of the disease. While the emerging themes did not immediately address oral 
intake, our data suggest that SKY can feasibly play a vital role in alleviating the disease 
burden of COPD more broadly through its influence on the mind, the body, the breath, 
and relationship between the three. 
Functional Relation Between SKY and Improved Consequences of COPD  
 I hypothesized that SKY would result in a functional decrease in perceived 
dyspnea, operationalized as WOB, SOB, DD, and DA, along with an improvement in 
mealtime enjoyment and reduction in mealtime difficulty. Fidelity of treatment was 
ensured by: (a) a trained data collector with fidelity frequency of 100% observing the 
intervention sessions and completing a checklist outlining whether the SKY instructor 
taught all the components and whether the participants were able to correctly perform 
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each component and (b) the SKY instructor documenting whether each component was 
taught and whether the participants were able to demonstrate the breathing techniques 
accurately after instruction. All of the participants who completed the program attended 
the complete three-day SKY training in its entirely, all of the components of the 
intervention were covered in the training, and all of the participants accurately 
demonstrated each of the four intervention components across the training.  
Dyspnea Perceptions  
Our results suggest that SKY positively impacted the perceptions of WOB, SOB, 
DD, and DA for at least some participants with COPD. Indicators of the improvements 
were based on visual analyses as well as Tau-U and LRR effect sizes. The 
nature of COPD is that even in stable, community-dwelling individuals, their breathing 
functions can vary from moment to moment. This pattern was certainly mirrored in the 
current data visualization as not all participants achieved a stable baseline or stability in 
the phases of the study. This variability was additionally evidenced by some 
of the large standard errors for LRR and the wide confidence intervals.  
Overall, many participants did grossly demonstrate a stabling of the level and 
trend in the four domains of dyspnea measured, often achieving less drastic variability in 
perceptions after SKY, especially as compared to the baseline period before the 
intervention. The changes in the dyspnea perceptions observed in the visual analyses 
corresponded to the Tau-U and LRR calculations, especially for Participants WA and RT. 
These two participants, in particular, were able to achieve improved variability, reaching 
a more stable pattern of the data with corresponding medium-high effects and large 
percentage changes across a number of the outcome measures.  
 
    
 
108
While SKY led to improvements in dyspnea to different degrees across the 
different participants, participants’ responses overall were more consistently apparent in 
the affective/distress domain associated with dyspnea as compared to the 
intensity/sensory domain. For example, based on LRR calculations, Participants WA and 
RT exhibited the most individual percentage change in dyspnea-related anxiety, and 
Participant RF had the greatest percentage change in dyspnea-related distress, followed 
by dyspnea-related anxiety. Participants WA and RT both also exhibited improvements in 
shortness of breath and work of breathing, respectively, although these changes were not 
as large in magnitude. Even in the presence of ‘Very Severe’ COPD (i.e., Participant PS), 
the greatest perceptual percentage changes were reported in dyspnea-related anxiety, 
followed by dyspnea-related distress. While this pattern was not present for all 
participants, there was a trend for more consistent improvements to be noted in the 
affective domain. For example, although Participant RK exhibited the greatest percentage 
change in shortness of breath, he also showed improvements in dyspnea-related distress. 
These findings that the affective components of dyspnea showed greater improvements, 
are consistent with a pilot study by Donesky-Cuenco et al. (2009). The researchers 
examined the benefits of yoga for individuals with COPD and found that while small 
effects were observed for dyspnea intensity after exertion (i.e., shortness of breath), there 
was a greater reduction in dyspnea-related distress in the yoga group as compared to the 
control group. One rationale for the greater response in the affective/distress domain 
relates to the bidirectional relationship between emotions and respiration. This 
bidirectional relationship allows for the emotions to be optimized through respiration, 
despite the disease process itself taking longer to reverse or influence (Arch & Craske, 
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2006; Boiten et al., 1994; Carrieri-Kohlman et al., 1993; Kaushik et al., 2006; Philippot et 
al., 2002). Despite the inconsistency of responses across participants in the current study, 
the overall data suggest that SKY can help to alleviate some of the chronic dyspnea 
burden experienced by individuals with COPD, at both the physiological and the psycho-
emotional levels.  
Interestingly, not all participants demonstrated strong perceptual changes in 
dyspnea. In particular, minimal perceptual changes were reported by Participants GG and 
JK. According to the participants’ COPD severity, these individuals also both presented 
with mild disease severity. It is plausible that due to the more limited symptomatic 
impacts of COPD at baseline, perceptual changes were consequently less noticeable after 
SKY and/or there was less potential for improvement.  
Our findings are of importance as dyspnea is common in COPD, yet often poorly 
managed (Swan et al., 2019). In general, up to 16% of individuals experience dyspnea, 
and up to 25% of accidents and emergency admissions are a product of dyspnea (Chin & 
Booth, 2016). Further, COPD-related dyspnea, and dyspnea in general, is often under-
recognized and undertreated (Smallwood et al., 2018). Despite being a physiologically-
rooted condition, this subjective experience of difficulty breathing also manifests in the 
psycho-emotional realms of life. COPD-related dyspnea is a major cause of disability and 
anxiety (GOLD, 2018). Dyspnea is linked to impeded activities of daily living, unplanned 
emergency room visits, and reduced quality of life (Swan et al., 2019). In actuality, 
dyspnea can be measured in different facets as individuals with COPD can distinguish 
affective dyspnea from the effects of chronic respiratory disease (Carrieri-Kohlman et al., 
1996). This differentiations between affective (i.e., DD and DA) and disease effect (i.e., 
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WOB and SOB) is certainly reflected in our data, where each participant demonstrated 
different degrees of effect sizes and percentage changes across the study phases. 
Our findings among individuals with COPD expand upon the research of the 
benefits of SKY for healthy individuals. Following SKY, healthy individuals have been 
reported to show significantly improved pulmonary function as measured by vital and 
forced vital capacities as well as a reduction in respiratory rate by 5% in one week and 
15% in 12 weeks  (Bodi et al., 2008; Chavhan et al., 2013; Kale et al., 2016; 
Sahasrabudhe et al., 2019; Seppälä et al., 2014; Somwanshi et al., 2013). While we did 
not collect physiologic measures of pulmonary function, the data from the current study 
showing improvements in perceived dyspnea mirror previous findings related to the 
respiratory system more broadly. Most likely our WOB and SOB measures are closely 
linked to the intensity/sensory aspects of pulmonary functioning, which can be affected 
by DD and DA, and vice versa, as the physiological and the psycho-emotional levels are 
synergistic. This relationship is supported by our data in that most participants 
demonstrated changes across the various facets of dyspnea. Unlike the previous studies 
among healthy individuals, we did not find overall improvement across the whole group. 
This is likely in part due to the heterogeneity of our small sample of participants, 
especially in terms of different COPD severities. Further, this likely reflects a difference 
between healthy participants, who exhibit relative stability in their respiratory 
functioning, and individuals with COPD, who experience greater variability day to day. 
The perceptual improvements in dyspnea observed in this study following SKY, 
particularly as related to work of breathing and shortness of breath, can be supported by 
previous literature that investigated underlying physiologic improvements. Individuals’ 
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perceived progress can be a result of strengthening of the respiratory muscles, increased 
excursions of the diaphragm and the lungs, and/or increased thoracic compliance 
(Vempati & Telles, 2002; Wenger, 1961). It is possible that by engaging in the active, 
volitional breathing required of the SKY intervention and home practice (vs. typical 
breathing that is spontaneous and involuntary), the respiratory muscles become 
strengthened. Further, yogic breathing is associated with a reduction in airway resistance 
(Mauch, 2008) and long-term yoga practice is associated with increased control of 
respiratory musculature such that individuals can consciously override typical 
physiological response of the respiratory centers (Vyas & Dikshit, 2002). Such practice 
can also lead to the relaxation of the respiratory muscles, induced by supraspinal 
mechanisms, which increases expiratory reserve volume, contributing to a rise in vital 
capacity (Vyas & Dikshit, 2002). Additionally, surfactant and prostaglandins can be 
released through physiological stimuli like lung inflation to near total lung capacity, 
which, in turn, increases lung compliance and decreases bronchiolar smooth muscle tone 
(Vyas & Dikshit, 2002). 
The improvements noted in dyspnea-related distress and anxiety in our study 
support the previous research on SKY’s influence on anxiety (e.g., Doria et al., 2015; 
Seppälä et al., 2014; Sharma et al., 2017). Significant reductions in anxiety have been 
found across many populations following SKY (e.g., individuals with generalized anxiety 
disorder with or without comorbidities, alcohol dependent individuals, United States 
military veterans). For example, 73% of individuals with generalized anxiety disorder 
who did not respond to medication and psychotherapy treatments showed a reduction in 
anxiety, and 41% of the same individuals experienced a complete remission (Katzman et 
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al., 2012). These changes may be associated with an increased parasympathetic 
dominance via vagal stimulation from vagal somatosensory afferents, leading to a 
resultant reduction in sympathetic activity (Brown & Gerbarg, 2005b; Vempati & Telles, 
2002; Wenger, 1961). The Polyvagal Theory also supports the role of the vagus nerve in 
regulating emotions, social connections, and fear (Porges, 2007). The various breathing 
techniques in SKY likely activate diverse fiber groups innervated by the vagus nerve, 
which passes through the throat, improving vagal tone and leading to improvements in 
mood and anxiety. Brown & Gerbarg (2005a) used a neurophysiologic model to explain 
the role of SKY in improving autonomic function, neuroendocrine release, emotional 
processing, and social bonding as a result of the activation of vagal afferents as well as 
activation of the limbic system, hippocampus, hypothalamus, amygdala, and stria 
terminalis. 
Ultimately, the physiological and psycho-emotional domains are related 
bidirectionally. Using this knowledge, our study approached the management of dyspnea 
for individuals with COPD through a broader lens than is typically used, focusing on 
improving both the physiology associated with dyspnea as well as the psycho-emotional 
distress associated with dyspnea. Targeting both the physiology and accompanying 
distress is crucial as interrupting the anxiety-dyspnea-anxiety cycle may ultimately allow 
individuals to be able to tolerate more activities of daily living and experience improved 
quality of life (Dudley et al., 1980). Importantly, the decreased COPD-related dyspnea 
burden associated with the SKY intervention provides further support for the psycho-
physiological relationships associated with dyspnea and chronic illness. For example, 
past research has suggested that even with improvement in the impairment, patients do 
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not always see these improvements mirrored in their perceived handicap (Ward et al., 
2002). This highlights the importance of targeting factors influencing patient perceptions 
related to functional disability as researchers continue to explore the inextricable 
relationship between physiology and psycho-emotions.  
Further support for the psycho-physiological relationships after SKY is evident in 
the descriptive survey data. For many participants, SKY resulted in a range of short-term 
and long-term benefits across both the physiological (i.e., COPD-related impact) and 
psycho-emotional (i.e., mood, affect) realms. For example, there was reduction in the 
means for Hospital Anxiety and Depression Scale across the study timepoints, and there 
was an increase in positive affect as well as a reduction in negative affect. In fact, two of 
the participants whose depression subscores were consistent with case or borderline case 
at baseline, improved to the normal range after SKY. Three of the participants, whose 
anxiety subscores were consistent with case or borderline case at baseline, improved to 
the normal range after SKY. Additionally, when comparing baseline scores to scores 10 
weeks after SKY, there was a decrease in the mean of the symptomatic impact of COPD 
based on the COPD Assessment Test. 
The current findings suggest that SKY can yield physiological and psycho-
emotional benefits for individuals with COPD. These findings are in alignment with the 
results from a number of previous reviews, systematic reviews, and meta-analyses across 
both the healthy elderly and COPD populations exploring the benefits of complementary 
and integrative intervention programs more broadly (Cramer et al., 2019; Li et al., 2018; 
Patel et al., 2012; Ratarasarn & Kundu, 2020; Tulloch et al., 2018). For example, based 
on quantitative and qualitative synthesis, one systematic review and meta-analysis 
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suggested that the benefits of yoga may exceed conventional exercise interventions for 
self-rated health status, aerobic fitness, and strength (Patel et al., 2012). Previous 
literature on the specific benefits of various complementary and integrative health 
interventions have mostly yielded results that support such interventions among the 
COPD population. Significant changes in anxiety, perception of dyspnea, and reduction 
in respiratory rate were reported after a meditation program (Reaves & Angosta, 2021). 
Improved pulmonary function, ability to ambulate, and quality of life were also noted 
after a 12-week yoga program (Kaminsky et al., 2017; Yudhawati & Hs, 2019). Another 
pilot study also reported that a 12-week yoga program yielded significant positive effects 
on dyspnea-related intensity and dyspnea-related distress (Donesky-Cuenco et al., 2009). 
The feasibility and compliance for an eight-week meditation program was reported, and 
the results revealed long-term benefits on psychological distress (Bensliman et al., 2020). 
SKY adds to the existing literature base in supporting the benefits of complementary and 
integrative interventions. 
However, not all of the previous research has yielded positive findings. One study 
revealed that an eight-week yoga and meditation program did not impact lung function 
for individuals with moderate-to-very-severe COPD (Rasam et al., 2019). An absence of 
a significant finding for the benefit of mindfulness-based stress reduction and relaxation 
response training was also reported in a randomized controlled trial (Mularski et al., 
2009). The discrepancies across the past research and the current one can be attributed to 
a few factors. Firstly, it is plausible that the different participants’ COPD severities across 
the studies contributed to the differences in findings. For example, of note, individuals 
with mild COPD in the current study exhibited the most limited benefits, if at all. The 
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inconsistent results could also be attributed to differences in treatment adherence as the 
characteristics of COPD (e.g., anxiety, depression, fear of dyspnea) can yield issues with 
adherence (Fischer et al., 2009; Qian et al., 2014; Yohannes et al., 2010). The amount of 
time required can serve as an additional variance. When compared to SKY, the previous 
studies required more substantial time commitments. Further, SKY is an evidence-based 
program that is taught per a manual, whereas other studies often appeared to utilize 
approaches from different sources, which may lead to questionable treatment fidelity and 
effectiveness. 
Mealtime Enjoyment/Difficulty and Swallowing Function 
In terms of rating mealtime enjoyment and difficulty after SKY, our participants 
demonstrated varying degrees of responses. For example, JL demonstrated a relatively 
high gain in mealtime enjoyment. However, this positive outcome was likely influenced 
by her experiencing dental issues at the beginning of the data collection, which was later 
resolved. Overall, the role that SKY plays in increasing mealtime enjoyment for 
individuals with COPD was not able to be fully captured in the current study, even 
though past research on SKY has revealed enhancement of optimism and life satisfaction 
in healthy adults (Divya et al., 2021; Goldstein et al., 2016; Goldstein et al., 2020; 
Kjellgren et al., 2007). Further, the minimal changes that were observed in mealtime 
enjoyment after SKY could often be explained by additional individual-level factors, 
such as the participants had not eaten, ate already, or had other conflicts at the time of the 
call. Thus, limited conclusions can be determined about the effects of SKY on mealtime 
enjoyment from the current study. 
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However, our data did suggest that individuals who exhibited the most consistent 
reduction in dyspnea burden across domains also demonstrated the greatest decreases in 
mealtime difficulty (i.e., WA and RT). In the work of Lin & Shune (2019), it was 
reported that dyspnea during oral intake can lead to negative emotions, like fear, anxiety, 
panic, which further deteriorate the breathing status (i.e., mind-body-breath feedback 
loop). This occurred even in the absence of diagnosed dysphagia, although many 
participants did report signs and symptoms suggestive of a swallowing impairment. Our 
current findings expand on this previous work by specifically targeting a reduction in 
dyspnea burden, potentially interrupting the mind-body-breath feedback loop and 
allowing for decreased perceived mealtime difficulty. Consequently, with the reduction in 
both dyspnea burden and the corresponding oral intake difficulties (i.e., taking less work 
to eat), it is possible that individuals with COPD may have more respiratory reserve for 
other activities of daily living (Dudley et al., 1980). In fact, when an individual struggles 
to breathe, the basic drive for respiration can override the drive for nutrition via oral 
intake. This creates clear downstream consequences, as malnutrition is an issue among 
individuals with COPD, with up to 60% of inpatients and 45% of outpatients being at risk 
(Hodson, 2016; Hoong et al., 2017). Unfortunately, malnutrition is an independent 
predictor of one-year mortality and healthcare utilization (e.g., increased risk of 
hospitalization, longer hospital stay, more readmissions, increased hospitalization costs 
by 20%) (Hoong et al., 2017). Also, underweight individuals with advanced but stable 
COPD have been reported to present with dysphagia that may not be self-recognized 
(Garand et al., 2018), further contributing to their nutritional concerns. Therefore, it is 
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plausible that reducing mealtime difficulties through decreased dyspnea may lead to more 
widespread benefits on nutrition and overall well-being.  
The relationship between decreased perceived dyspnea burden and improved 
eating and/or swallowing function is also supported by the results for the Eating 
Assessment Tool (EAT-10) and the physical, functional, and emotional aspects of the 
Dysphagia Handicap Index (DHI). When comparing the baseline group mean of EAT-10 
with the group mean after SKY, there was a slight reduction, indicating improvements. 
Although there was a slight increase in the group mean for perceived swallowing 
difficulty on the DHI, when comparing baseline scores across the different domains with 
those after SKY, there was an overall reduction of the means, suggestive of 
improvements. The slight increase in perceived swallowing difficulty might be attributed 
to increased self-awareness after SKY (Goldstein et al., 2020; Seppälä et al., 2020), 
particularly as related to breathing, as no participants reported any major medical issues 
during the span of the research. Thus, the observed link between dyspnea and perceived 
mealtime difficulty described above likely corresponded, at least in part, to the impact of 
dyspnea burden on the swallowing mechanism, especially with regard to safety and 
airway invasion.  
The elevated respiratory rate associated with dyspnea commonly observed in 
individuals with COPD (Berliner et al., 2016) is linked to discoordination between 
breathing and swallowing in this population (Shaker et al., 1992). Both consequences of 
dyspnea (i.e., increased respiratory rate and discoordinated breathing and swallowing) 
increase the risk of airway invasion during oral intake (Steele & Cichero, 2014), and 
COPD is a common risk factor for aspiration pneumonia (Santo et al., 2021). When an 
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individual is at risk for aspiration pneumonia and/or present with dysphagia, malnutrition 
can be expected (Langmore, 1999). Further, dyspnea itself can yield a negative oral 
intake experience (affectively); these negative emotions then worsen the existing dyspnea 
(Lin & Shune, 2019). Dysphagia can also impede quality of life more broadly by 
impacting affect, mood, and social interactions (Eslick & Talley, 2008; McHorney et al., 
2000; Nguyen et al., 2005; Plowman-Prine et al., 2009). Together, underlying dyspnea 
and dysphagia likely magnify a negative oral intake experience, contributing to further 
widespread, cascading consequences (e.g., increased anxiety, increased dyspnea, 
decreased intake). It is therefore pivotal to tap into the management of dyspnea from the 
root, through approaches like SKY, in order to optimize fundamental activities of daily 
living, like oral intake, particularly given concomitant dysphagia.  
Study Limitations 
There are a few important limitations of this study to note. Firstly, a number of 
limitations arose related to the single-case data collection. It was not always possible to 
obtain consistent worsening, improving, or stabling data points for every participant 
within a group before the start of the intervention or the start of the next group 
intervention. This was likely due to the nature of COPD, where breathing status varies 
frequently across activities and across days. Additionally, even though the data collection 
times were individually discussed with each participant and agreed upon, sometimes 
participants had not eaten their evening dinner, ate earlier, or had other conflicts at the 
time of the planned phone call. Thus, while the team called the participants at these 
consistent times each day, the true reflection of breathing status immediately after oral 
intake was perhaps more confined. Also, retrospectively, it appeared that some 
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participants comprehended the mealtime enjoyment question differently at times, 
focusing on their enjoyment of the specific food consumed during that meal versus the 
broader intention of exploring the mealtime process itself.  
Secondly, there were a few needed restrictions related to the design and 
participants. In terms of the design of both portions of the study, most of the data 
collected was limited to within-a-month timeframe after the SKY intervention. The 
longer-term impacts of the intervention and maintenance of the intervention effects for 
individuals with COPD remains unexplored. Additionally, the makeup of the participants 
limits the generalizability of the findings. It would be beneficial for future studies to more 
closely mirror the demographics of the overall COPD population in terms of, for 
example, disease severity. As noted, those individuals with milder COPD may not yield 
the same immediate benefit from treatment. Further, all of our participants were in the 
age range of 61 to 74. Presbyphagia, or age-related changes in swallowing function, 
could potentially impact the influence of COPD on swallowing function and alter 
treatment effectiveness. Relatedly, no direct measures of swallowing status were 
collected, and dysphagia status was not used as inclusion/exclusion criteria. Although 
previous work has suggested that even participants without diagnosed dysphagia 
experience negative effects of COPD on the oral intake process, the current results cannot 
provide specific conclusions regarding the influence of SKY on dysphagia more 
specifically. Lastly, due to COVID-19, the study was limited to remote intervention 
presentation and data collection, relying on subjective experience/reporting rather than 
physiological measurements. The physiological aspects of breathing, oral intake, and the 
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interactions of the two could not be collected as a result. Despite these limitations, the 
study’s findings lay the foundation and invitation for further research directions.     
Future Directions 
 This study forms the foundation for future investigations into the viability and 
effectiveness of SKY for individuals with COPD. Firstly, to promote the generalizability 
of the results, scaling up the study is needed. Increasing the sample size, recruiting a 
more heterogenous sample with respect to race and ethnicity and COPD status, involving 
multiple sites/regions, and including a control group will help strengthen the findings. 
Secondly, physiological measures like pre- and post- pulmonary functions (e.g., 
respiratory rate, FEV1, FVC, FEV1/FVC) can shed light on actual respiratory changes and 
allow for more generalizable conclusions to be drawn about the link between 
physiological changes, perceived changes in dyspnea, and emotional responses to 
dyspnea. Similarly, swallowing physiology and its interaction with pulmonary status 
during oral intake should be explored to further the objective benefits of SKY and 
provide clear clinical implications for individuals with dysphagia. Thirdly, longer-term 
follow-up is warranted to investigate the true functional effects and maintenance of these 
effects over time. Also, longer-term follow-up would allow for additional outcome 
measures of relevance to be collected, such as nutritional status, which may be important 
for individuals with COPD experiencing dyspnea and dysphagia. Finally, the study 
results suggest the potential for benefit from SKY among other clinical populations with 
respiratory impairments (e.g., end-stage cancer, congestive heart failure, COVID-19). 
Thus, future work can expand to other populations who are affected by their breathing, in 
order to investigate the effectiveness of SKY in these different groups. 
 




COPD is the third-leading cause of death and a major cause of disability 
worldwide. Its significant impacts are not limited to the physiological realm. COPD 
greatly influences the psycho-emotional and social facets of life as well. These COPD-
related manifestations can interact with and magnify each other, creating a snowball 
effect that ultimately worsens health and quality of life. Therefore, it is crucial that COPD 
management more comprehensively targets the physiological and psycho-emotional 
consequences of the disease. This study is the first to explore the feasibility and 
acceptability of SKY among individuals with COPD as well as the relation between SKY 
and dyspnea perceptions in this population. Supported by our qualitative, single-case, and 
descriptive data, as well as the absence of any adverse events, the results suggest proof of 
concept that SKY can help alleviate aspects of COPD disease burden related to the mind, 
body, and breath more broadly as well as reduce the cyclical effect of the disease 
sequalae. Findings preliminarily support the presence of decreased perceived dyspnea 
surrounding work of breath, shortness of breath, dyspnea-related distress, and dyspnea-
related anxiety after SKY, including following oral intake, an activity of daily life when 
these characteristics are known to be high. Importantly, despite differing COPD 
severities, the findings here support that following SKY, individuals with stable COPD 
can experience improvements in the physiological and psycho-emotional domains of the 
disease consequences and, by extension, improvements in quality of life. This suggests 
that SKY may be a valuable supplement to more traditional therapeutic approaches for 
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